UCSF Navigation Bar

UCSF Departments of Pathology & Laboratory Medicine Home Page

Lab Manual for Moffitt-Long and Mount Zion

Lab Manual for SFGH

Internal Resources

Gamma Glutamyl Transferase (GGT; CPT-4 82977)

ICD-9 Code Description
003.1 SALMONELLA SEPTICEMIA
006.0 ACUTE AMEBIC DYSENTERY WITHOUT ABSCESS
006.1 CHRONIC INTESTINAL AMEBIASIS WITHOUT ABSCESS
006.2 AMEBIC NONDYSENTERIC COLITIS
006.3 AMEBIC LIVER ABSCESS
006.4 AMEBIC LUNG ABSCESS
006.5 AMEBIC BRAIN ABSCESS
006.6 AMEBIC SKIN ULCERATION
006.8 AMEBIC INFECTION OF OTHER SITES
006.9 AMEBIASIS UNSPECIFIED
014.00 TUBERCULOUS PERITONITIS UNSPECIFIED EXAMINATION
014.01 TUBERCULOUS PERITONITIS BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION NOT DONE
014.02 TUBERCULOUS PERITONITIS BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION RESULTS UNKNOWN (AT PRESENT)
014.03 TUBERCULOUS PERITONITIS TUBERCLE BACILLI FOUND (IN SPUTUM) BY MICROSCOPY
014.04 TUBERCULOUS PERITONITIS TUBERCLE BACILLI NOT FOUND (IN SPUTUM) BY MICROSCOPY BUT FOUND BY BACTERIAL CULTURE
014.05 TUBERCULOUS PERITONITIS TUBERCLE BACILLI NOT FOUND BY BACTERIOLOGICAL EXAMINATION BUT TUBERCULOSIS CONFIRMED HISTOLOGICALLY
014.06 TUBERCULOUS PERITONITIS TUBERCLE BACILLI NOT FOUND BY BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION BUT TUBERCULOSIS CONFIRMED BY OTHER METHODS (INOCULATION OF ANIMALS)
014.80 OTHER TUBERCULOSIS OF INTESTINES AND MESENTERIC GLANDS UNSPECIFIED EXAMINATION
014.81 OTHER TUBERCULOSIS OF INTESTINES AND MESENTERIC GLANDS BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION NOT DONE
014.82 OTHER TUBERCULOSIS OF INTESTINES AND MESENTERIC GLANDS BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION RESULTS UNKNOWN (AT PRESENT)
014.83 OTHER TUBERCULOSIS OF INTESTINES AND MESENTERIC GLANDS TUBERCLE BACILLI FOUND (IN SPUTUM) BY MICROSCOPY
014.84 OTHER TUBERCULOSIS OF INTESTINES AND MESENTERIC GLANDS TUBERCLE BACILLI NOT FOUND (IN SPUTUM) BY MICROSCOPY BUT FOUND BY BACTERIAL CULTURE
014.85 OTHER TUBERCULOSIS OF INTESTINES AND MESENTERIC GLANDS TUBERCLE BACILLI NOT FOUND BY BACTERIOLOGICAL EXAMINATION BUT TUBERCULOSIS CONFIRMED HISTOLOGICALLY
014.86 OTHER TUBERCULOSIS OF INTESTINES AND MESENTERIC GLANDS TUBERCLE BACILLI NOT FOUND BY BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION BUT TUBERCULOSIS CONFIRMED BY OTHER METHODS (INOCULATION OF ANIMALS)
017.90 TUBERCULOSIS OF OTHER SPECIFIED ORGANS UNSPECIFIED EXAMINATION
017.91 TUBERCULOSIS OF OTHER SPECIFIED ORGANS BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION NOT DONE
017.92 TUBERCULOSIS OF OTHER SPECIFIED ORGANS BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION RESULTS UNKNOWN (AT PRESENT)
017.93 TUBERCULOSIS OF OTHER SPECIFIED ORGANS TUBERCLE BACILLI FOUND (IN SPUTUM) BY MICROSCOPY
017.94 TUBERCULOSIS OF OTHER SPECIFIED ORGANS TUBERCLE BACILLI NOT FOUND (IN SPUTUM) BY MICROSCOPY BUT FOUND BY BACTERIAL CULTURE
017.95 TUBERCULOSIS OF OTHER SPECIFIED ORGANS TUBERCLE BACILLI NOT FOUND BY BACTERIOLOGICAL EXAMINATION BUT TUBERCULOSIS CONFIRMED HISTOLOGICALLY
017.96 TUBERCULOSIS OF OTHER SPECIFIED ORGANS TUBERCLE BACILLI NOT FOUND BY BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION BUT TUBERCULOSIS CONFIRMED BY OTHER METHODS (INOCULATION OF ANIMALS)
018.90 UNSPECIFIED MILIARY TUBERCULOSIS UNSPECIFIED EXAMINATION
018.91 UNSPECIFIED MILIARY TUBERCULOSIS BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION NOT DONE
018.92 UNSPECIFIED MILIARY TUBERCULOSIS BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION RESULTS UNKNOWN (AT PRESENT)
018.93 UNSPECIFIED MILIARY TUBERCULOSIS TUBERCLE BACILLI FOUND (IN SPUTUM) BY MICROSCOPY
018.94 UNSPECIFIED MILIARY TUBERCULOSIS TUBERCLE BACILLI NOT FOUND (IN SPUTUM) BY MICROSCOPY BUT FOUND BY BACTERIAL CULTURE
018.95 UNSPECIFIED MILIARY TUBERCULOSIS TUBERCLE BACILLI NOT FOUND BY BACTERIOLOGICAL EXAMINATION BUT TUBERCULOSIS CONFIRMED HISTOLOGICALLY
018.96 UNSPECIFIED MILIARY TUBERCULOSIS TUBERCLE BACILLI NOT FOUND BY BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION BUT TUBERCULOSIS CONFIRMED BY OTHER METHODS (INOCULATION OF ANIMALS)
020.0 BUBONIC PLAGUE
020.1 CELLULOCUTANEOUS PLAGUE
020.2 SEPTICEMIC PLAGUE
020.3 PRIMARY PNEUMONIC PLAGUE
020.4 SECONDARY PNEUMONIC PLAGUE
020.5 PNEUMONIC PLAGUE UNSPECIFIED
020.8 OTHER SPECIFIED TYPES OF PLAGUE
020.9 PLAGUE UNSPECIFIED
022.3 ANTHRAX SEPTICEMIA
027.0 LISTERIOSIS
027.1 ERYSIPELOTHRIX INFECTION
030.1 TUBERCULOID LEPROSY (TYPE T)
032.83 DIPHTHERITIC PERITONITIS
036.1 MENINGOCOCCAL ENCEPHALITIS
036.2 MENINGOCOCCEMIA
038.0 STREPTOCOCCAL SEPTICEMIA
038.10 STAPHYLOCOCCAL SEPTICEMIA UNSPECIFIED
038.11 METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS SEPTICEMIA
038.12 METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS SEPTICEMIA
038.19 OTHER STAPHYLOCOCCAL SEPTICEMIA
038.2 PNEUMOCOCCAL SEPTICEMIA
038.3 SEPTICEMIA DUE TO ANAEROBES
038.40 SEPTICEMIA DUE TO GRAM-NEGATIVE ORGANISM UNSPECIFIED
038.41 SEPTICEMIA DUE TO HEMOPHILUS INFLUENZAE (H. INFLUENZAE)
038.42 SEPTICEMIA DUE TO ESCHERICHIA COLI (E. COLI)
038.43 SEPTICEMIA DUE TO PSEUDOMONAS
038.44 SEPTICEMIA DUE TO SERRATIA
038.49 OTHER SEPTICEMIA DUE TO GRAM-NEGATIVE ORGANISMS
038.8 OTHER SPECIFIED SEPTICEMIAS
038.9 UNSPECIFIED SEPTICEMIA
038.12 METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS SEPTICEMIA
039.2 ABDOMINAL ACTINOMYCOTIC INFECTION
040.0 GAS GANGRENE
042 HUMAN IMMUNODEFICIENCY VIRUS (HIV) DISEASE
054.0 ECZEMA HERPETICUM
054.5 HERPETIC SEPTICEMIA
060.0 SYLVATIC YELLOW FEVER
060.1 URBAN YELLOW FEVER
070.0 VIRAL HEPATITIS A WITH HEPATIC COMA
070.1 VIRAL HEPATITIS A WITHOUT HEPATIC COMA
070.20 VIRAL HEPATITIS B WITH HEPATIC COMA ACUTE OR UNSPECIFIED WITHOUT HEPATITIS DELTA
070.21 VIRAL HEPATITIS B WITH HEPATIC COMA ACUTE OR UNSPECIFIED WITH HEPATITIS DELTA
070.22 CHRONIC VIRAL HEPATITIS B WITH HEPATIC COMA WITHOUT HEPATITIS DELTA
070.23 CHRONIC VIRAL HEPATITIS B WITH HEPATIC COMA WITH HEPATITIS DELTA
070.30 VIRAL HEPATITIS B WITHOUT HEPATIC COMA ACUTE OR UNSPECIFIED WITHOUT HEPATITIS DELTA
070.31 VIRAL HEPATITIS B WITHOUT HEPATIC COMA ACUTE OR UNSPECIFIED WITH HEPATITIS DELTA
070.32 CHRONIC VIRAL HEPATITIS B WITHOUT HEPATIC COMA WITHOUT HEPATITIS DELTA
070.33 CHRONIC VIRAL HEPATITIS B WITHOUT HEPATIC COMA WITH HEPATITIS DELTA
070.41 ACUTE HEPATITIS C WITH HEPATIC COMA
070.42 HEPATITIS DELTA WITHOUT ACTIVE HEPATITIS B DISEASE WITH HEPATIC COMA HEPATITIS DELTA WITH HEPATITIS B CARRIER STATE
070.43 HEPATITIS E WITH HEPATIC COMA
070.44 CHRONIC HEPATITIS C WITH HEPATIC COMA
070.49 OTHER SPECIFIED VIRAL HEPATITIS WITH HEPATIC COMA
070.51 ACUTE HEPATITIS C WITHOUT MENTION OF HEPATIC COMA
070.52 HEPATITIS DELTA WITHOUT ACTIVE HEPATITIS B DISEASE OR HEPATIC COMA
070.53 HEPATITIS E WITHOUT HEPATIC COMA
070.54 CHRONIC HEPATITIS C WITHOUT HEPATIC COMA
070.59 OTHER SPECIFIED VIRAL HEPATITIS WITHOUT HEPATIC COMA
070.6 UNSPECIFIED VIRAL HEPATITIS WITH HEPATIC COMA
070.70 UNSPECIFIED VIRAL HEPATITIS C WITHOUT HEPATIC COMA
070.71 UNSPECIFIED VIRAL HEPATITIS C WITH HEPATIC COMA
070.9 UNSPECIFIED VIRAL HEPATITIS WITHOUT HEPATIC COMA
072.71 MUMPS HEPATITIS
073.0 ORNITHOSIS WITH PNEUMONIA
074.8 OTHER SPECIFIED DISEASES DUE TO COXSACKIE VIRUS
075 INFECTIOUS MONONUCLEOSIS
078.5 CYTOMEGALOVIRAL DISEASE
079.99 UNSPECIFIED VIRAL INFECTION
082.0 SPOTTED FEVERS
082.1 BOUTONNEUSE FEVER
082.2 NORTH ASIAN TICK FEVER
082.3 QUEENSLAND TICK TYPHUS
082.40 UNSPECIFIED EHRLICHIOSIS
082.41 EHRLICHIOSIS CHAFEENSIS (E CHAFEENSIS)
082.49 OTHER EHRLICHIOSIS
082.8 OTHER SPECIFIED TICK-BORNE RICKETTSIOSES
082.9 TICK-BORNE RICKETTSIOSIS UNSPECIFIED
084.9 OTHER PERNICIOUS COMPLICATIONS OF MALARIA
086.1 CHAGAS' DISEASE WITH OTHER ORGAN INVOLVEMENT
088.81 LYME DISEASE
091.62 SECONDARY SYPHILITIC HEPATITIS
095.3 SYPHILIS OF LIVER
100.0 LEPTOSPIROSIS ICTEROHEMORRHAGICA
112.5 DISSEMINATED CANDIDIASIS
115.00 INFECTION BY HISTOPLASMA CAPSULATUM WITHOUT MANIFESTATION
120.9 SCHISTOSOMIASIS UNSPECIFIED
121.1 CLONORCHIASIS
121.3 FASCIOLIASIS
122.0 ECHINOCOCCUS GRANULOSUS INFECTION OF LIVER
122.5 ECHINOCOCCUS MULTILOCULARIS INFECTION OF LIVER
122.8 ECHINOCOCCOSIS UNSPECIFIED OF LIVER
122.9 ECHINOCOCCOSIS OTHER AND UNSPECIFIED
130.5 HEPATITIS DUE TO TOXOPLASMOSIS
135 SARCOIDOSIS
150.0 MALIGNANT NEOPLASM OF CERVICAL ESOPHAGUS
150.1 MALIGNANT NEOPLASM OF THORACIC ESOPHAGUS
150.2 MALIGNANT NEOPLASM OF ABDOMINAL ESOPHAGUS
150.3 MALIGNANT NEOPLASM OF UPPER THIRD OF ESOPHAGUS
150.4 MALIGNANT NEOPLASM OF MIDDLE THIRD OF ESOPHAGUS
150.5 MALIGNANT NEOPLASM OF LOWER THIRD OF ESOPHAGUS
150.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED PART OF ESOPHAGUS
150.9 MALIGNANT NEOPLASM OF ESOPHAGUS UNSPECIFIED SITE
151.0 MALIGNANT NEOPLASM OF CARDIA
151.1 MALIGNANT NEOPLASM OF PYLORUS
151.2 MALIGNANT NEOPLASM OF PYLORIC ANTRUM
151.3 MALIGNANT NEOPLASM OF FUNDUS OF STOMACH
151.4 MALIGNANT NEOPLASM OF BODY OF STOMACH
151.5 MALIGNANT NEOPLASM OF LESSER CURVATURE OF STOMACH UNSPECIFIED
151.6 MALIGNANT NEOPLASM OF GREATER CURVATURE OF STOMACH UNSPECIFIED
151.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF STOMACH
151.9 MALIGNANT NEOPLASM OF STOMACH UNSPECIFIED SITE
152.0 MALIGNANT NEOPLASM OF DUODENUM
152.1 MALIGNANT NEOPLASM OF JEJUNUM
152.2 MALIGNANT NEOPLASM OF ILEUM
152.3 MALIGNANT NEOPLASM OF MECKEL'S DIVERTICULUM
152.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF SMALL INTESTINE
152.9 MALIGNANT NEOPLASM OF SMALL INTESTINE UNSPECIFIED SITE
153.0 MALIGNANT NEOPLASM OF HEPATIC FLEXURE
153.1 MALIGNANT NEOPLASM OF TRANSVERSE COLON
153.2 MALIGNANT NEOPLASM OF DESCENDING COLON
153.3 MALIGNANT NEOPLASM OF SIGMOID COLON
153.4 MALIGNANT NEOPLASM OF CECUM
153.5 MALIGNANT NEOPLASM OF APPENDIX VERMIFORMIS
153.6 MALIGNANT NEOPLASM OF ASCENDING COLON
153.7 MALIGNANT NEOPLASM OF SPLENIC FLEXURE
153.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF LARGE INTESTINE
153.9 MALIGNANT NEOPLASM OF COLON UNSPECIFIED SITE
154.0 MALIGNANT NEOPLASM OF RECTOSIGMOID JUNCTION
154.1 MALIGNANT NEOPLASM OF RECTUM
154.2 MALIGNANT NEOPLASM OF ANAL CANAL
154.3 MALIGNANT NEOPLASM OF ANUS UNSPECIFIED SITE
154.8 MALIGNANT NEOPLASM OF OTHER SITES OF RECTUM RECTOSIGMOID JUNCTION AND ANUS
155.0 MALIGNANT NEOPLASM OF LIVER PRIMARY
155.1 MALIGNANT NEOPLASM OF INTRAHEPATIC BILE DUCTS
155.2 MALIGNANT NEOPLASM OF LIVER NOT SPECIFIED AS PRIMARY OR SECONDARY
156.0 MALIGNANT NEOPLASM OF GALLBLADDER
156.1 MALIGNANT NEOPLASM OF EXTRAHEPATIC BILE DUCTS
156.2 MALIGNANT NEOPLASM OF AMPULLA OF VATER
156.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF GALLBLADDER AND EXTRAHEPATIC BILE DUCTS
156.9 MALIGNANT NEOPLASM OF BILIARY TRACT PART UNSPECIFIED SITE
157.0 MALIGNANT NEOPLASM OF HEAD OF PANCREAS
157.1 MALIGNANT NEOPLASM OF BODY OF PANCREAS
157.2 MALIGNANT NEOPLASM OF TAIL OF PANCREAS
157.3 MALIGNANT NEOPLASM OF PANCREATIC DUCT
157.4 MALIGNANT NEOPLASM OF ISLETS OF LANGERHANS
157.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF PANCREAS
157.9 MALIGNANT NEOPLASM OF PANCREAS PART UNSPECIFIED
158.0 MALIGNANT NEOPLASM OF RETROPERITONEUM
158.8 MALIGNANT NEOPLASM OF SPECIFIED PARTS OF PERITONEUM
158.9 MALIGNANT NEOPLASM OF PERITONEUM UNSPECIFIED
159.0 MALIGNANT NEOPLASM OF INTESTINAL TRACT PART UNSPECIFIED
159.1 MALIGNANT NEOPLASM OF SPLEEN NOT ELSEWHERE CLASSIFIED
159.8 MALIGNANT NEOPLASM OF OTHER SITES OF DIGESTIVE SYSTEM AND INTRA-ABDOMINAL ORGANS
159.9 MALIGNANT NEOPLASM OF ILL-DEFINED SITES WITHIN THE DIGESTIVE ORGANS AND PERITONEUM
160.0 MALIGNANT NEOPLASM OF NASAL CAVITIES
160.1 MALIGNANT NEOPLASM OF AUDITORY TUBE MIDDLE EAR AND MASTOID AIR CELLS
160.2 MALIGNANT NEOPLASM OF MAXILLARY SINUS
160.3 MALIGNANT NEOPLASM OF ETHMOIDAL SINUS
160.4 MALIGNANT NEOPLASM OF FRONTAL SINUS
160.5 MALIGNANT NEOPLASM OF SPHENOIDAL SINUS
160.8 MALIGNANT NEOPLASM OF OTHER ACCESSORY SINUSES
160.9 MALIGNANT NEOPLASM OF ACCESSORY SINUS UNSPECIFIED
161.0 MALIGNANT NEOPLASM OF GLOTTIS
161.1 MALIGNANT NEOPLASM OF SUPRAGLOTTIS
161.2 MALIGNANT NEOPLASM OF SUBGLOTTIS
161.3 MALIGNANT NEOPLASM OF LARYNGEAL CARTILAGES
161.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF LARYNX
161.9 MALIGNANT NEOPLASM OF LARYNX UNSPECIFIED
162.0 MALIGNANT NEOPLASM OF TRACHEA
162.2 MALIGNANT NEOPLASM OF MAIN BRONCHUS
162.3 MALIGNANT NEOPLASM OF UPPER LOBE BRONCHUS OR LUNG
162.4 MALIGNANT NEOPLASM OF MIDDLE LOBE BRONCHUS OR LUNG
162.5 MALIGNANT NEOPLASM OF LOWER LOBE BRONCHUS OR LUNG
162.8 MALIGNANT NEOPLASM OF OTHER PARTS OF BRONCHUS OR LUNG
162.9 MALIGNANT NEOPLASM OF BRONCHUS AND LUNG UNSPECIFIED
163.0 MALIGNANT NEOPLASM OF PARIETAL PLEURA
163.1 MALIGNANT NEOPLASM OF VISCERAL PLEURA
163.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF PLEURA
163.9 MALIGNANT NEOPLASM OF PLEURA UNSPECIFIED
164.0 MALIGNANT NEOPLASM OF THYMUS
164.1 MALIGNANT NEOPLASM OF HEART
164.2 MALIGNANT NEOPLASM OF ANTERIOR MEDIASTINUM
164.3 MALIGNANT NEOPLASM OF POSTERIOR MEDIASTINUM
164.8 MALIGNANT NEOPLASM OF OTHER PARTS OF MEDIASTINUM
164.9 MALIGNANT NEOPLASM OF MEDIASTINUM PART UNSPECIFIED
165.0 MALIGNANT NEOPLASM OF UPPER RESPIRATORY TRACT PART UNSPECIFIED
165.8 MALIGNANT NEOPLASM OF OTHER SITES WITHIN THE RESPIRATORY SYSTEM AND INTRATHORACIC ORGANS
165.9 MALIGNANT NEOPLASM OF ILL-DEFINED SITES WITHIN THE RESPIRATORY SYSTEM
170.0 MALIGNANT NEOPLASM OF BONES OF SKULL AND FACE EXCEPT MANDIBLE
170.1 MALIGNANT NEOPLASM OF MANDIBLE
170.2 MALIGNANT NEOPLASM OF VERTEBRAL COLUMN EXCLUDING SACRUM AND COCCYX
170.3 MALIGNANT NEOPLASM OF RIBS STERNUM AND CLAVICLE
170.4 MALIGNANT NEOPLASM OF SCAPULA AND LONG BONES OF UPPER LIMB
170.5 MALIGNANT NEOPLASM OF SHORT BONES OF UPPER LIMB
170.6 MALIGNANT NEOPLASM OF PELVIC BONES SACRUM AND COCCYX
170.7 MALIGNANT NEOPLASM OF LONG BONES OF LOWER LIMB
170.8 MALIGNANT NEOPLASM OF SHORT BONES OF LOWER LIMB
170.9 MALIGNANT NEOPLASM OF BONE AND ARTICULAR CARTILAGE SITE UNSPECIFIED
171.0 MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF HEAD FACE AND NECK
171.2 MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF UPPER LIMB INCLUDING SHOULDER
171.3 MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF LOWER LIMB INCLUDING HIP
171.4 MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF THORAX
171.5 MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF ABDOMEN
171.6 MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF PELVIS
171.7 MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF TRUNK UNSPECIFIED
171.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF CONNECTIVE AND OTHER SOFT TISSUE
171.9 MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE SITE UNSPECIFIED
172.0 MALIGNANT MELANOMA OF SKIN OF LIP
172.1 MALIGNANT MELANOMA OF SKIN OF EYELID INCLUDING CANTHUS
172.2 MALIGNANT MELANOMA OF SKIN OF EAR AND EXTERNAL AUDITORY CANAL
172.3 MALIGNANT MELANOMA OF SKIN OF OTHER AND UNSPECIFIED PARTS OF FACE
172.4 MALIGNANT MELANOMA OF SKIN OF SCALP AND NECK
172.5 MALIGNANT MELANOMA OF SKIN OF TRUNK EXCEPT SCROTUM
172.6 MALIGNANT MELANOMA OF SKIN OF UPPER LIMB INCLUDING SHOULDER
172.7 MALIGNANT MELANOMA OF SKIN OF LOWER LIMB INCLUDING HIP
172.8 MALIGNANT MELANOMA OF OTHER SPECIFIED SITES OF SKIN
172.9 MELANOMA OF SKIN SITE UNSPECIFIED
173.0 OTHER MALIGNANT NEOPLASM OF SKIN OF LIP
173.1 OTHER MALIGNANT NEOPLASM OF SKIN OF EYELID INCLUDING CANTHUS
173.2 OTHER MALIGNANT NEOPLASM OF SKIN OF EAR AND EXTERNAL AUDITORY CANAL
173.3 OTHER MALIGNANT NEOPLASM OF SKIN OF OTHER AND UNSPECIFIED PARTS OF FACE
173.4 OTHER MALIGNANT NEOPLASM OF SCALP AND SKIN OF NECK
173.5 OTHER MALIGNANT NEOPLASM OF SKIN OF TRUNK EXCEPT SCROTUM
173.6 OTHER MALIGNANT NEOPLASM OF SKIN OF UPPER LIMB INCLUDING SHOULDER
173.7 OTHER MALIGNANT NEOPLASM OF SKIN OF LOWER LIMB INCLUDING HIP
173.8 OTHER MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF SKIN
173.9 OTHER MALIGNANT NEOPLASM OF SKIN SITE UNSPECIFIED
174.0 MALIGNANT NEOPLASM OF NIPPLE AND AREOLA OF FEMALE BREAST
174.1 MALIGNANT NEOPLASM OF CENTRAL PORTION OF FEMALE BREAST
174.2 MALIGNANT NEOPLASM OF UPPER-INNER QUADRANT OF FEMALE BREAST
174.3 MALIGNANT NEOPLASM OF LOWER-INNER QUADRANT OF FEMALE BREAST
174.4 MALIGNANT NEOPLASM OF UPPER-OUTER QUADRANT OF FEMALE BREAST
174.5 MALIGNANT NEOPLASM OF LOWER-OUTER QUADRANT OF FEMALE BREAST
174.6 MALIGNANT NEOPLASM OF AXILLARY TAIL OF FEMALE BREAST
174.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF FEMALE BREAST
174.9 MALIGNANT NEOPLASM OF BREAST (FEMALE) UNSPECIFIED SITE
175.0 MALIGNANT NEOPLASM OF NIPPLE AND AREOLA OF MALE BREAST
175.9 MALIGNANT NEOPLASM OF OTHER AND UNSPECIFIED SITES OF MALE BREAST
176.0 KAPOSI'S SARCOMA SKIN
176.1 KAPOSI'S SARCOMA SOFT TISSUE
176.2 KAPOSI'S SARCOMA PALATE
176.3 KAPOSI'S SARCOMA GASTROINTESTINAL SITES
176.4 KAPOSI'S SARCOMA LUNG
176.5 KAPOSI'S SARCOMA LYMPH NODES
176.8 KAPOSI'S SARCOMA OTHER SPECIFIED SITES
176.9 KAPOSI'S SARCOMA UNSPECIFIED SITE
179 MALIGNANT NEOPLASM OF UTERUS-PART UNS
180.0 MALIGNANT NEOPLASM OF ENDOCERVIX
180.1 MALIGNANT NEOPLASM OF EXOCERVIX
180.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF CERVIX
180.9 MALIGNANT NEOPLASM OF CERVIX UTERI UNSPECIFIED SITE
181 MALIGNANT NEOPLASM OF PLACENTA
182.0 MALIGNANT NEOPLASM OF CORPUS UTERI EXCEPT ISTHMUS
182.1 MALIGNANT NEOPLASM OF ISTHMUS
182.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF BODY OF UTERUS
183.0 MALIGNANT NEOPLASM OF OVARY
183.2 MALIGNANT NEOPLASM OF FALLOPIAN TUBE
183.3 MALIGNANT NEOPLASM OF BROAD LIGAMENT OF UTERUS
183.4 MALIGNANT NEOPLASM OF PARAMETRIUM
183.5 MALIGNANT NEOPLASM OF ROUND LIGAMENT OF UTERUS
183.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF UTERINE ADNEXA
183.9 MALIGNANT NEOPLASM OF UTERINE ADNEXA UNSPECIFIED SITE
184.0 MALIGNANT NEOPLASM OF VAGINA
184.1 MALIGNANT NEOPLASM OF LABIA MAJORA
184.2 MALIGNANT NEOPLASM OF LABIA MINORA
184.3 MALIGNANT NEOPLASM OF CLITORIS
184.4 MALIGNANT NEOPLASM OF VULVA UNSPECIFIED SITE
184.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF FEMALE GENITAL ORGANS
184.9 MALIGNANT NEOPLASM OF FEMALE GENITAL ORGAN SITE UNSPECIFIED
185 MALIGNANT NEOPLASM OF PROSTATE
186.0 MALIGNANT NEOPLASM OF UNDESCENDED TESTIS
186.9 MALIGNANT NEOPLASM OF OTHER AND UNSPECIFIED TESTIS
187.1 MALIGNANT NEOPLASM OF PREPUCE
187.2 MALIGNANT NEOPLASM OF GLANS PENIS
187.3 MALIGNANT NEOPLASM OF BODY OF PENIS
187.4 MALIGNANT NEOPLASM OF PENIS PART UNSPECIFIED
187.5 MALIGNANT NEOPLASM OF EPIDIDYMIS
187.6 MALIGNANT NEOPLASM OF SPERMATIC CORD
187.7 MALIGNANT NEOPLASM OF SCROTUM
187.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF MALE GENITAL ORGANS
187.9 MALIGNANT NEOPLASM OF MALE GENITAL ORGAN SITE UNSPECIFIED
188.0 MALIGNANT NEOPLASM OF TRIGONE OF URINARY BLADDER
188.1 MALIGNANT NEOPLASM OF DOME OF URINARY BLADDER
188.2 MALIGNANT NEOPLASM OF LATERAL WALL OF URINARY BLADDER
188.3 MALIGNANT NEOPLASM OF ANTERIOR WALL OF URINARY BLADDER
188.4 MALIGNANT NEOPLASM OF POSTERIOR WALL OF URINARY BLADDER
188.5 MALIGNANT NEOPLASM OF BLADDER NECK
188.6 MALIGNANT NEOPLASM OF URETERIC ORIFICE
188.7 MALIGNANT NEOPLASM OF URACHUS
188.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF BLADDER
188.9 MALIGNANT NEOPLASM OF BLADDER PART UNSPECIFIED
189.0 MALIGNANT NEOPLASM OF KIDNEY EXCEPT PELVIS
189.1 MALIGNANT NEOPLASM OF RENAL PELVIS
189.2 MALIGNANT NEOPLASM OF URETER
189.3 MALIGNANT NEOPLASM OF URETHRA
189.4 MALIGNANT NEOPLASM OF PARAURETHRAL GLANDS
189.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF URINARY ORGANS
189.9 MALIGNANT NEOPLASM OF URINARY ORGAN SITE UNSPECIFIED
200.00 RETICULOSARCOMA UNSPECIFIED SITE
200.01 RETICULOSARCOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK
200.02 RETICULOSARCOMA INVOLVING INTRATHORACIC LYMPH NODES
200.03 RETICULOSARCOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES
200.04 RETICULOSARCOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
200.05 RETICULOSARCOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
200.06 RETICULOSARCOMA INVOLVING INTRAPELVIC LYMPH NODES
200.07 RETICULOSARCOMA INVOLVING SPLEEN
200.08 RETICULOSARCOMA INVOLVING LYMPH NODES OF MULTIPLE SITES
200.10 LYMPHOSARCOMA UNSPECIFIED SITE
200.11 LYMPHOSARCOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK
200.12 LYMPHOSARCOMA INVOLVING INTRATHORACIC LYMPH NODES
200.13 LYMPHOSARCOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES
200.14 LYMPHOSARCOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
200.15 LYMPHOSARCOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
200.16 LYMPHOSARCOMA INVOLVING INTRAPELVIC LYMPH NODES
200.17 LYMPHOSARCOMA INVOLVING SPLEEN
200.18 LYMPHOSARCOMA INVOLVING LYMPH NODES OF MULTIPLE SITES
200.20 BURKITT'S TUMOR OR LYMPHOMA UNSPECIFIED SITE
200.21 BURKITT'S TUMOR OR LYMPHOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK
200.22 BURKITT'S TUMOR OR LYMPHOMA INVOLVING INTRATHORACIC LYMPH NODES
200.23 BURKITT'S TUMOR OR LYMPHOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES
200.24 BURKITT'S TUMOR OR LYMPHOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
200.25 BURKITT'S TUMOR OR LYMPHOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
200.26 BURKITT'S TUMOR OR LYMPHOMA INVOLVING INTRAPELVIC LYMPH NODES
200.27 BURKITT'S TUMOR OR LYMPHOMA INVOLVING SPLEEN
200.28 BURKITT'S TUMOR OR LYMPHOMA INVOLVING LYMPH NODES OF MULTIPLE SITES
200.30 MARGINAL ZONE LYMPHOMA UNSPECIFIED SITE
200.31 MARGINAL ZONE LYMPHOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK
200.32 MARGINAL ZONE LYMPHOMA INVOLVING INTRATHORACIC LYMPH NODES
200.33 MARGINAL ZONE LYMPHOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES
200.34 MARGINAL ZONE LYMPHOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
200.35 MARGINAL ZONE LYMPHOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
200.36 MARGINAL ZONE LYMPHOMA INVOLVING INTRAPELVIC LYMPH NODES
200.37 MARGINAL ZONE LYMPHOMA INVOLVING SPLEEN
200.38 MARGINAL ZONE LYMPHOMA INVOLVING LYMPH NODES OF MULTIPLE SITES
200.40 MANTLE CELL LYMPHOMA UNSPECIFIED SITE
200.41 MANTLE CELL LYMPHOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK
200.42 MANTLE CELL LYMPHOMA INVOLVING INTRATHORACIC LYMPH NODES
200.43 MANTLE CELL LYMPHOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES
200.44 MANTLE CELL LYMPHOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
200.45 MANTLE CELL LYMPHOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
200.46 MANTLE CELL LYMPHOMA INVOLVING INTRAPELVIC LYMPH NODES
200.47 MANTLE CELL LYMPHOMA INVOLVING SPLEEN
200.48 MANTLE CELL LYMPHOMA INVOLVING LYMPH NODES OF MULTIPLE SITES
200.50 PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA UNSPECIFIED SITE
200.51 PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK
200.52 PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING INTRATHORACIC LYMPH NODES
200.53 PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES
200.54 PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
200.55 PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
200.56 PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING INTRAPELVIC LYMPH NODES
200.57 PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING SPLEEN
200.58 PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING LYMPH NODES OF MULTIPLE SITES
200.60 ANAPLASTIC LARGE CELL LYMPHOMA UNSPECIFIED SITE
200.61 ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK
200.62 ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING INTRATHORACIC LYMPH NODES
200.63 ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES
200.64 ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
200.65 ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
200.66 ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING INTRAPELVIC LYMPH NODES
200.67 ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING SPLEEN
200.68 ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF MULTIPLE SITES
200.70 LARGE CELL LYMPHOMA UNSPECIFIED SITE
200.71 LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK
200.72 LARGE CELL LYMPHOMA INVOLVING INTRATHORACIC LYMPH NODES
200.73 LARGE CELL LYMPHOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES
200.74 LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
200.75 LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
200.76 LARGE CELL LYMPHOMA INVOLVING INTRAPELVIC LYMPH NODES
200.77 LARGE CELL LYMPHOMA INVOLVING SPLEEN
200.78 LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF MULTIPLE SITES
200.80 OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA UNSPECIFIED SITE
200.81 OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK
200.82 OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA INVOLVING INTRATHORACIC LYMPH NODES
200.83 OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES
200.84 OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
200.85 OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
200.86 OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA INVOLVING INTRAPELVIC LYMPH NODES
200.87 OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA INVOLVING SPLEEN
200.88 OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA INVOLVING LYMPH NODES OF MULTIPLE SITES
201.00 HODGKIN'S PARAGRANULOMA UNSPECIFIED SITE
201.01 HODGKIN'S PARAGRANULOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK
201.02 HODGKIN'S PARAGRANULOMA INVOLVING INTRATHORACIC LYMPH NODES
201.03 HODGKIN'S PARAGRANULOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES
201.04 HODGKIN'S PARAGRANULOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
201.05 HODGKIN'S PARAGRANULOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
201.06 HODGKIN'S PARAGRANULOMA INVOLVING INTRAPELVIC LYMPH NODES
201.07 HODGKIN'S PARAGRANULOMA INVOLVING SPLEEN
201.08 HODGKIN'S PARAGRANULOMA INVOLVING LYMPH NODES OF MULTIPLE SITES
201.10 HODGKIN'S GRANULOMA UNSPECIFIED SITE
201.11 HODGKIN'S GRANULOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK
201.12 HODGKIN'S GRANULOMA INVOLVING INTRATHORACIC LYMPH NODES
201.13 HODGKIN'S GRANULOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES
201.14 HODGKIN'S GRANULOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
201.15 HODGKIN'S GRANULOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
201.16 HODGKIN'S GRANULOMA INVOLVING INTRAPELVIC LYMPH NODES
201.17 HODGKIN'S GRANULOMA INVOLVING SPLEEN
201.18 HODGKIN'S GRANULOMA INVOLVING LYMPH NODES OF MULTIPLE SITES
201.20 HODGKIN'S SARCOMA UNSPECIFIED SITE
201.21 HODGKIN'S SARCOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK
201.22 HODGKIN'S SARCOMA INVOLVING INTRATHORACIC LYMPH NODES
201.23 HODGKIN'S SARCOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES
201.24 HODGKIN'S SARCOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
201.25 HODGKIN'S SARCOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
201.26 HODGKIN'S SARCOMA INVOLVING INTRAPELVIC LYMPH NODES
201.27 HODGKIN'S SARCOMA INVOLVING SPLEEN
201.28 HODGKIN'S SARCOMA INVOLVING LYMPH NODES OF MULTIPLE SITES
201.40 HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE UNSPECIFIED SITE
201.41 HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE INVOLVING LYMPH NODES OF HEAD FACE AND NECK
201.42 HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE INVOLVING INTRATHORACIC LYMPH NODES
201.43 HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE INVOLVING INTRA-ABDOMINAL LYMPH NODES
201.44 HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
201.45 HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
201.46 HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE INVOLVING INTRAPELVIC LYMPH NODES
201.47 HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE INVOLVING SPLEEN
201.48 HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE INVOLVING LYMPH NODES OF MULTIPLE SITES
201.50 HODGKIN'S DISEASE NODULAR SCLEROSIS UNSPECIFIED SITE
201.51 HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING LYMPH NODES OF HEAD FACE AND NECK
201.52 HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING INTRATHORACIC LYMPH NODES
201.53 HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING INTRA-ABDOMINAL LYMPH NODES
201.54 HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
201.55 HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
201.56 HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING INTRAPELVIC LYMPH NODES
201.57 HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING SPLEEN
201.58 HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING LYMPH NODES OF MULTIPLE SITES
201.60 HODGKIN'S DISEASE MIXED CELLULARITY UNSPECIFIED SITE
201.61 HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING LYMPH NODES OF HEAD FACE AND NECK
201.62 HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING INTRATHORACIC LYMPH NODES
201.63 HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING INTRA-ABDOMINAL LYMPH NODES
201.64 HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
201.65 HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
201.66 HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING INTRAPELVIC LYMPH NODES
201.67 HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING SPLEEN
201.68 HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING LYMPH NODES OF MULTIPLE SITES
201.70 HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION UNSPECIFIED SITE
201.71 HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING LYMPH NODES OF HEAD FACE AND NECK
201.72 HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING INTRATHORACIC LYMPH NODES
201.73 HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING INTRA-ABDOMINAL LYMPH NODES
201.74 HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
201.75 HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
201.76 HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING INTRAPELVIC LYMPH NODES
201.77 HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING SPLEEN
201.78 HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING LYMPH NODES OF MULTIPLE SITES
201.90 HODGKIN'S DISEASE UNSPECIFIED TYPE UNSPECIFIED SITE
201.91 HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING LYMPH NODES OF HEAD FACE AND NECK
201.92 HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING INTRATHORACIC LYMPH NODES
201.93 HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING INTRA-ABDOMINAL LYMPH NODES
201.94 HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
201.95 HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
201.96 HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING INTRAPELVIC LYMPH NODES
201.97 HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING SPLEEN
201.98 HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING LYMPH NODES OF MULTIPLE SITES
202.00 NODULAR LYMPHOMA UNSPECIFIED SITE
202.01 NODULAR LYMPHOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK
202.02 NODULAR LYMPHOMA INVOLVING INTRATHORACIC LYMPH NODES
202.03 NODULAR LYMPHOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES
202.04 NODULAR LYMPHOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
202.05 NODULAR LYMPHOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
202.06 NODULAR LYMPHOMA INVOLVING INTRAPELVIC LYMPH NODES
202.07 NODULAR LYMPHOMA INVOLVING SPLEEN
202.08 NODULAR LYMPHOMA INVOLVING LYMPH NODES OF MULTIPLE SITES
202.10 MYCOSIS FUNGOIDES UNSPECIFIED SITE
202.11 MYCOSIS FUNGOIDES INVOLVING LYMPH NODES OF HEAD FACE AND NECK
202.12 MYCOSIS FUNGOIDES INVOLVING INTRATHORACIC LYMPH NODES
202.13 MYCOSIS FUNGOIDES INVOLVING INTRA-ABDOMINAL LYMPH NODES
202.14 MYCOSIS FUNGOIDES INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
202.15 MYCOSIS FUNGOIDES INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
202.16 MYCOSIS FUNGOIDES INVOLVING INTRAPELVIC LYMPH NODES
202.17 MYCOSIS FUNGOIDES INVOLVING SPLEEN
202.18 MYCOSIS FUNGOIDES INVOLVING LYMPH NODES OF MULTIPLE SITES
202.20 SEZARY'S DISEASE UNSPECIFIED SITE
202.21 SEZARY'S DISEASE INVOLVING LYMPH NODES OF HEAD FACE AND NECK
202.22 SEZARY'S DISEASE INVOLVING INTRATHORACIC LYMPH NODES
202.23 SEZARY'S DISEASE INVOLVING INTRA-ABDOMINAL LYMPH NODES
202.24 SEZARY'S DISEASE INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
202.25 SEZARY'S DISEASE INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
202.26 SEZARY'S DISEASE INVOLVING INTRAPELVIC LYMPH NODES
202.27 SEZARY'S DISEASE INVOLVING SPLEEN
202.28 SEZARY'S DISEASE INVOLVING LYMPH NODES OF MULTIPLE SITES
202.30 MALIGNANT HISTIOCYTOSIS UNSPECIFIED SITE
202.31 MALIGNANT HISTIOCYTOSIS INVOLVING LYMPH NODES OF HEAD FACE AND NECK
202.32 MALIGNANT HISTIOCYTOSIS INVOLVING INTRATHORACIC LYMPH NODES
202.33 MALIGNANT HISTIOCYTOSIS INVOLVING INTRA-ABDOMINAL LYMPH NODES
202.34 MALIGNANT HISTIOCYTOSIS INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
202.35 MALIGNANT HISTIOCYTOSIS INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
202.36 MALIGNANT HISTIOCYTOSIS INVOLVING INTRAPELVIC LYMPH NODES
202.37 MALIGNANT HISTIOCYTOSIS INVOLVING SPLEEN
202.38 MALIGNANT HISTIOCYTOSIS INVOLVING LYMPH NODES OF MULTIPLE SITES
202.40 LEUKEMIC RETICULOENDOTHELIOSIS UNSPECIFIED SITE
202.41 LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING LYMPH NODES OF HEAD FACE AND NECK
202.42 LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING INTRATHORACIC LYMPH NODES
202.43 LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING INTRA-ABDOMINAL LYMPH NODES
202.44 LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING LYMPH NODES OF AXILLA AND UPPER ARM
202.45 LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
202.46 LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING INTRAPELVIC LYMPH NODES
202.47 LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING SPLEEN
202.48 LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING LYMPH NODES OF MULTIPLE SITES
202.50 LETTERER-SIWE DISEASE UNSPECIFIED SITE
202.51 LETTERER-SIWE DISEASE INVOLVING LYMPH NODES OF HEAD FACE AND NECK
202.52 LETTERER-SIWE DISEASE INVOLVING INTRATHORACIC LYMPH NODES
202.53 LETTERER-SIWE DISEASE INVOLVING INTRA-ABDOMINAL LYMPH NODES
202.54 LETTERER-SIWE DISEASE INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
202.55 LETTERER-SIWE DISEASE INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
202.56 LETTERER-SIWE DISEASE INVOLVING INTRAPELVIC LYMPH NODES
202.57 LETTERER-SIWE DISEASE INVOLVING SPLEEN
202.58 LETTERER-SIWE DISEASE INVOLVING LYMPH NODES OF MULTIPLE SITES
202.60 MALIGNANT MAST CELL TUMORS UNSPECIFIED SITE
202.61 MALIGNANT MAST CELL TUMORS INVOLVING LYMPH NODES OF HEAD FACE AND NECK
202.62 MALIGNANT MAST CELL TUMORS INVOLVING INTRATHORACIC LYMPH NODES
202.63 MALIGNANT MAST CELL TUMORS INVOLVING INTRA-ABDOMINAL LYMPH NODES
202.64 MALIGNANT MAST CELL TUMORS INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
202.65 MALIGNANT MAST CELL TUMORS INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
202.66 MALIGNANT MAST CELL TUMORS INVOLVING INTRAPELVIC LYMPH NODES
202.67 MALIGNANT MAST CELL TUMORS INVOLVING SPLEEN
202.68 MALIGNANT MAST CELL TUMORS INVOLVING LYMPH NODES OF MULTIPLE SITES
202.70 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED SITE
202.71 PERIPHERAL T-CELL LYMPHOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK
202.72 PERIPHERAL T-CELL LYMPHOMA INVOLVING INTRATHORACIC LYMPH NODES
202.73 PERIPHERAL T-CELL LYMPHOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES
202.74 PERIPHERAL T-CELL LYMPHOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
202.75 PERIPHERAL T-CELL LYMPHOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
202.76 PERIPHERAL T-CELL LYMPHOMA INVOLVING INTRAPELVIC LYMPH NODES
202.77 PERIPHERAL T-CELL LYMPHOMA INVOLVING SPLEEN
202.78 PERIPHERAL T-CELL LYMPHOMA INVOLVING LYMPH NODES OF MULTIPLE SITES
202.80 OTHER MALIGNANT LYMPHOMAS UNSPECIFIED SITE
202.81 OTHER MALIGNANT LYMPHOMAS INVOLVING LYMPH NODES OF HEAD FACE AND NECK
202.82 OTHER MALIGNANT LYMPHOMAS INVOLVING INTRATHORACIC LYMPH NODES
202.83 OTHER MALIGNANT LYMPHOMAS INVOLVING INTRA-ABDOMINAL LYMPH NODES
202.84 OTHER MALIGNANT LYMPHOMAS INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
202.85 OTHER MALIGNANT LYMPHOMAS INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
202.86 OTHER MALIGNANT LYMPHOMAS INVOLVING INTRAPELVIC LYMPH NODES
202.87 OTHER MALIGNANT LYMPHOMAS INVOLVING SPLEEN
202.88 OTHER MALIGNANT LYMPHOMAS INVOLVING LYMPH NODES OF MULTIPLE SITES
202.90 OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC TISSUE UNSPECIFIED SITE
202.91 OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC TISSUE INVOLVING LYMPH NODES OF HEAD FACE AND NECK
202.92 OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC TISSUE INVOLVING INTRATHORACIC LYMPH NODES
202.93 OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC TISSUE INVOLVING INTRA-ABDOMINAL LYMPH NODES
202.94 OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC TISSUE INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB
202.95 OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC TISSUE INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB
202.96 OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC TISSUE INVOLVING INTRAPELVIC LYMPH NODES
202.97 OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC TISSUE INVOLVING SPLEEN
202.98 OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC TISSUE INVOLVING LYMPH NODES OF MULTIPLE SITES
203.00 MULTIPLE MYELOMA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
203.01 MULTIPLE MYELOMA IN REMISSION
203.02 MULTIPLE MYELOMA IN RELAPSE
203.10 PLASMA CELL LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
203.11 PLASMA CELL LEUKEMIA IN REMISSION
203.12 PLASMA CELL LEUKEMIA IN RELAPSE
203.80 OTHER IMMUNOPROLIFERATIVE NEOPLASMS WITHOUT MENTION OF HAVING ACHIEVED REMISSION
203.81 OTHER IMMUNOPROLIFERATIVE NEOPLASMS IN REMISSION
203.82 OTHER IMMUNOPROLIFERATIVE NEOPLASMS IN RELAPSE
204.00 ACUTE LYMPHOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
204.01 ACUTE LYMPHOID LEUKEMIA IN REMISSION
204.02 ACUTE LYMPHOID LEUKEMIA IN RELAPSE
204.10 CHRONIC LYMPHOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
204.11 CHRONIC LYMPHOID LEUKEMIA IN REMISSION
204.12 CHRONIC LYMPHOID LEUKEMIA IN RELAPSE
204.20 SUBACUTE LYMPHOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
204.21 SUBACUTE LYMPHOID LEUKEMIA IN REMISSION
204.22 SUBACUTE LYMPHOID LEUKEMIA IN RELAPSE
204.80 OTHER LYMPHOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
204.81 OTHER LYMPHOID LEUKEMIA IN REMISSION
204.82 OTHER LYMPHOID LEUKEMIA IN RELAPSE
204.90 UNSPECIFIED LYMPHOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
204.91 UNSPECIFIED LYMPHOID LEUKEMIA IN REMISSION
204.92 UNSPECIFIED LYMPHOID LEUKEMIA IN RELAPSE
205.00 ACUTE MYELOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
205.01 ACUTE MYELOID LEUKEMIA IN REMISSION
205.02 ACUTE MYELOID LEUKEMIA IN RELAPSE
205.10 CHRONIC MYELOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
205.11 CHRONIC MYELOID LEUKEMIA IN REMISSION
205.12 CHRONIC MYELOID LEUKEMIA IN RELAPSE
205.20 SUBACUTE MYELOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
205.21 SUBACUTE MYELOID LEUKEMIA IN REMISSION
205.22 SUBACUTE MYELOID LEUKEMIA IN RELAPSE
205.30 MYELOID SARCOMA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
205.31 MYELOID SARCOMA IN REMISSION
205.32 MYELOID SARCOMA IN RELAPSE
205.80 OTHER MYELOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
205.81 OTHER MYELOID LEUKEMIA IN REMISSION
205.82 OTHER MYELOID LEUKEMIA IN RELAPSE
205.90 UNSPECIFIED MYELOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
205.91 UNSPECIFIED MYELOID LEUKEMIA IN REMISSION
205.92 UNSPECIFIED MYELOID LEUKEMIA IN RELAPSE
206.00 ACUTE MONOCYTIC LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
206.01 ACUTE MONOCYTIC LEUKEMIA IN REMISSION
206.02 ACUTE MONOCYTIC LEUKEMIA IN RELAPSE
206.10 CHRONIC MONOCYTIC LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
206.11 CHRONIC MONOCYTIC LEUKEMIA IN REMISSION
206.12 CHRONIC MONOCYTIC LEUKEMIA IN RELAPSE
206.20 SUBACUTE MONOCYTIC LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
206.21 SUBACUTE MONOCYTIC LEUKEMIA IN REMISSION
206.22 SUBACUTE MONOCYTIC LEUKEMIA IN RELAPSE
206.80 OTHER MONOCYTIC LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
206.81 OTHER MONOCYTIC LEUKEMIA IN REMISSION
206.82 OTHER MONOCYTIC LEUKEMIA IN RELAPSE
206.90 UNSPECIFIED MONOCYTIC LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
206.91 UNSPECIFIED MONOCYTIC LEUKEMIA IN REMISSION
206.92 UNSPECIFIED MONOCYTIC LEUKEMIA IN RELAPSE
207.00 ACUTE ERYTHREMIA AND ERYTHROLEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
207.01 ACUTE ERYTHREMIA AND ERYTHROLEUKEMIA IN REMISSION
207.02 ACUTE ERYTHREMIA AND ERYTHROLEUKEMIA IN RELAPSE
207.10 CHRONIC ERYTHREMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
207.11 CHRONIC ERYTHREMIA IN REMISSION
207.12 CHRONIC ERYTHREMIA IN RELAPSE
207.20 MEGAKARYOCYTIC LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
207.21 MEGAKARYOCYTIC LEUKEMIA IN REMISSION
207.22 MEGAKARYOCYTIC LEUKEMIA IN RELAPSE
207.80 OTHER SPECIFIED LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
207.81 OTHER SPECIFIED LEUKEMIA IN REMISSION
207.82 OTHER SPECIFIED LEUKEMIA IN RELAPSE
208.00 ACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE WITHOUT MENTION OF HAVING ACHIEVED REMISSION
208.01 ACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE IN REMISSION
208.02 ACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE IN RELAPSE
208.10 CHRONIC LEUKEMIA OF UNSPECIFIED CELL TYPE WITHOUT MENTION OF HAVING ACHIEVED REMISSION
208.11 CHRONIC LEUKEMIA OF UNSPECIFIED CELL TYPE IN REMISSION
208.12 CHRONIC LEUKEMIA OF UNSPECIFIED CELL TYPE IN RELAPSE
208.20 SUBACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE WITHOUT MENTION OF HAVING ACHIEVED REMISSION
208.21 SUBACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE IN REMISSION
208.22 SUBACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE IN RELAPSE
208.80 OTHER LEUKEMIA OF UNSPECIFIED CELL TYPE WITHOUT MENTION OF HAVING ACHIEVED REMISSION
208.81 OTHER LEUKEMIA OF UNSPECIFIED CELL TYPE IN REMISSION
208.82 OTHER LEUKEMIA OF UNSPECIFIED CELL TYPE IN RELAPSE
208.90 UNSPECIFIED LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED REMISSION
208.91 UNSPECIFIED LEUKEMIA IN REMISSION
208.92 UNSPECIFIED LEUKEMIA IN RELAPSE
209.20 MALIGNANT CARCINOID TUMOR OF UNKNOWN PRIMARY SITE
209.21 MALIGNANT CARCINOID TUMOR OF THE BRONCHUS AND LUNG
209.22 MALIGNANT CARCINOID TUMOR OF THE THYMUS
209.23 MALIGNANT CARCINOID TUMOR OF THE STOMACH
209.24 MALIGNANT CARCINOID TUMOR OF THE KIDNEY
209.25 MALIGNANT CARCINOID TUMOR OF THE FOREGUT NOT OTHERWISE SPECIFIED
209.26 MALIGNANT CARCINOID TUMOR OF THE MIDGUT NOT OTHERWISE SPECIFIED
209.27 MALIGNANT CARCINOID TUMOR OF THE HINDGUT NOT OTHERWISE SPECIFIED
209.29 MALIGNANT CARCINOID TUMOR OF OTHER SITES
211.5 BENIGN NEOPLASM OF LIVER AND BILIARY PASSAGES
211.6 BENIGN NEOPLASM OF PANCREAS EXCEPT ISLETS OF LANGERHANS
211.7 BENIGN NEOPLASM OF ISLETS OF LANGERHANS
228.04 HEMANGIOMA OF INTRA-ABDOMINAL STRUCTURES
230.7 CARCINOMA IN SITU OF OTHER AND UNSPECIFIED PARTS OF INTESTINE
230.8 CARCINOMA IN SITU OF LIVER AND BILIARY SYSTEM
230.9 CARCINOMA IN SITU OF OTHER AND UNSPECIFIED DIGESTIVE ORGANS
235.0 NEOPLASM OF UNCERTAIN BEHAVIOR OF MAJOR SALIVARY GLANDS
235.1 NEOPLASM OF UNCERTAIN BEHAVIOR OF LIP ORAL CAVITY AND PHARYNX
235.2 NEOPLASM OF UNCERTAIN BEHAVIOR OF STOMACH INTESTINES AND RECTUM
235.3 NEOPLASM OF UNCERTAIN BEHAVIOR OF LIVER AND BILIARY PASSAGES
235.4 NEOPLASM OF UNCERTAIN BEHAVIOR OF RETROPERITONEUM AND PERITONEUM
235.5 NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED DIGESTIVE ORGANS
235.6 NEOPLASM OF UNCERTAIN BEHAVIOR OF LARYNX
235.7 NEOPLASM OF UNCERTAIN BEHAVIOR OF TRACHEA BRONCHUS AND LUNG
235.8 NEOPLASM OF UNCERTAIN BEHAVIOR OF PLEURA THYMUS AND MEDIASTINUM
235.9 NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED RESPIRATORY ORGANS
236.0 NEOPLASM OF UNCERTAIN BEHAVIOR OF UTERUS
236.1 NEOPLASM OF UNCERTAIN BEHAVIOR OF PLACENTA
236.2 NEOPLASM OF UNCERTAIN BEHAVIOR OF OVARY
236.3 NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED FEMALE GENITAL ORGANS
236.4 NEOPLASM OF UNCERTAIN BEHAVIOR OF TESTIS
236.5 NEOPLASM OF UNCERTAIN BEHAVIOR OF PROSTATE
236.6 NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED MALE GENITAL ORGANS
236.7 NEOPLASM OF UNCERTAIN BEHAVIOR OF BLADDER
236.90 NEOPLASM OF UNCERTAIN BEHAVIOR OF URINARY ORGAN UNSPECIFIED
236.91 NEOPLASM OF UNCERTAIN BEHAVIOR OF KIDNEY AND URETER
236.99 NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED URINARY ORGANS
237.0 NEOPLASM OF UNCERTAIN BEHAVIOR OF PITUITARY GLAND AND CRANIOPHARYNGEAL DUCT
237.1 NEOPLASM OF UNCERTAIN BEHAVIOR OF PINEAL GLAND
237.2 NEOPLASM OF UNCERTAIN BEHAVIOR OF ADRENAL GLAND
237.3 NEOPLASM OF UNCERTAIN BEHAVIOR OF PARAGANGLIA
237.4 NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED ENDOCRINE GLANDS
237.5 NEOPLASM OF UNCERTAIN BEHAVIOR OF BRAIN AND SPINAL CORD
237.6 NEOPLASM OF UNCERTAIN BEHAVIOR OF MENINGES
237.70 NEUROFIBROMATOSIS UNSPECIFIED
237.71 NEUROFIBROMATOSIS TYPE 1 VON RECKLINGHAUSEN'S DISEASE
237.72 NEUROFIBROMATOSIS TYPE 2 ACOUSTIC NEUROFIBROMATOSIS
237.9 NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED PARTS OF NERVOUS SYSTEM
238.0 NEOPLASM OF UNCERTAIN BEHAVIOR OF BONE AND ARTICULAR CARTILAGE
238.1 NEOPLASM OF UNCERTAIN BEHAVIOR OF CONNECTIVE AND OTHER SOFT TISSUE
238.2 NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN
238.3 NEOPLASM OF UNCERTAIN BEHAVIOR OF BREAST
238.4 POLYCYTHEMIA VERA
238.5 NEOPLASM OF UNCERTAIN BEHAVIOR OF HISTIOCYTIC AND MAST CELLS
238.6 NEOPLASM OF UNCERTAIN BEHAVIOR OF PLASMA CELLS
238.71 ESSENTIAL THROMBOCYTHEMIA
238.72 LOW GRADE MYELODYSPLASTIC SYNDROME LESIONS
238.73 HIGH GRADE MYELODYSPLASTIC SYNDROME LESIONS
238.74 MYELODYSPLASTIC SYNDROME WITH 5Q DELETION
238.75 MYELODYSPLASTIC SYNDROME UNSPECIFIED
238.76 MYELOFIBROSIS WITH MYELOID METAPLASIA
238.77 POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD)
238.79 NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER LYMPHATIC AND HEMATOPOIETIC TISSUES
238.8 NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER SPECIFIED SITES
238.9 NEOPLASM OF UNCERTAIN BEHAVIOR SITE UNSPECIFIED
239.0 NEOPLASM OF UNSPECIFIED NATURE OF DIGESTIVE SYSTEM
250.00 DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION TYPE II OR UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED
250.01 DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION TYPE I [JUVENILE TYPE] NOT STATED AS UNCONTROLLED
250.02 DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION TYPE II OR UNSPECIFIED TYPE UNCONTROLLED
250.03 DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION TYPE I [JUVENILE TYPE] UNCONTROLLED
250.10 DIABETES WITH KETOACIDOSIS TYPE II OR UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED
250.11 DIABETES WITH KETOACIDOSIS TYPE I [JUVENILE TYPE] NOT STATED AS UNCONTROLLED
250.12 DIABETES WITH KETOACIDOSIS TYPE II OR UNSPECIFIED TYPE UNCONTROLLED
250.13 DIABETES WITH KETOACIDOSIS TYPE I [JUVENILE TYPE] UNCONTROLLED
250.20 DIABETES WITH HYPEROSMOLARITY TYPE II OR UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED
250.21 DIABETES WITH HYPEROSMOLARITY TYPE I [JUVENILE TYPE] NOT STATED AS UNCONTROLLED
250.22 DIABETES WITH HYPEROSMOLARITY TYPE II OR UNSPECIFIED TYPE UNCONTROLLED
250.23 DIABETES WITH HYPEROSMOLARITY TYPE I [JUVENILE TYPE] UNCONTROLLED
250.30 DIABETES WITH OTHER COMA TYPE II OR UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED
250.31 DIABETES WITH OTHER COMA TYPE I [JUVENILE TYPE] NOT STATED AS UNCONTROLLED
250.32 DIABETES WITH OTHER COMA TYPE II OR UNSPECIFIED TYPE UNCONTROLLED
250.33 DIABETES WITH OTHER COMA TYPE I [JUVENILE TYPE] UNCONTROLLED
250.40 DIABETES WITH RENAL MANIFESTATIONS TYPE II OR UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED
250.41 DIABETES WITH RENAL MANIFESTATIONS TYPE I [JUVENILE TYPE] NOT STATED AS UNCONTROLLED
250.42 DIABETES WITH RENAL MANIFESTATIONS TYPE II OR UNSPECIFIED TYPE UNCONTROLLED
250.43 DIABETES WITH RENAL MANIFESTATIONS TYPE I [JUVENILE TYPE] UNCONTROLLED
250.50 DIABETES WITH OPHTHALMIC MANIFESTATIONS TYPE II OR UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED
250.51 DIABETES WITH OPHTHALMIC MANIFESTATIONS TYPE I [JUVENILE TYPE] NOT STATED AS UNCONTROLLED
250.52 DIABETES WITH OPHTHALMIC MANIFESTATIONS TYPE II OR UNSPECIFIED TYPE UNCONTROLLED
250.53 DIABETES WITH OPHTHALMIC MANIFESTATIONS TYPE I [JUVENILE TYPE] UNCONTROLLED
250.60 DIABETES WITH NEUROLOGICAL MANIFESTATIONS TYPE II OR UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED
250.61 DIABETES WITH NEUROLOGICAL MANIFESTATIONS TYPE I [JUVENILE TYPE] NOT STATED AS UNCONTROLLED
250.62 DIABETES WITH NEUROLOGICAL MANIFESTATIONS TYPE II OR UNSPECIFIED TYPE UNCONTROLLED
250.63 DIABETES WITH NEUROLOGICAL MANIFESTATIONS TYPE I [JUVENILE TYPE] UNCONTROLLED
250.70 DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS TYPE II OR UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED
250.71 DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS TYPE I [JUVENILE TYPE] NOT STATED AS UNCONTROLLED
250.72 DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS TYPE II OR UNSPECIFIED TYPE UNCONTROLLED
250.73 DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS TYPE I [JUVENILE TYPE] UNCONTROLLED
250.80 DIABETES WITH OTHER SPECIFIED MANIFESTATIONS TYPE II OR UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED
250.81 DIABETES WITH OTHER SPECIFIED MANIFESTATIONS TYPE I [JUVENILE TYPE] NOT STATED AS UNCONTROLLED
250.82 DIABETES WITH OTHER SPECIFIED MANIFESTATIONS TYPE II OR UNSPECIFIED TYPE UNCONTROLLED
250.83 DIABETES WITH OTHER SPECIFIED MANIFESTATIONS TYPE I [JUVENILE TYPE] UNCONTROLLED
250.90 DIABETES WITH UNSPECIFIED COMPLICATION TYPE II OR UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED
250.91 DIABETES WITH UNSPECIFIED COMPLICATION TYPE I [JUVENILE TYPE] NOT STATED AS UNCONTROLLED
250.92 DIABETES WITH UNSPECIFIED COMPLICATION TYPE II OR UNSPECIFIED TYPE UNCONTROLLED
250.93 DIABETES WITH UNSPECIFIED COMPLICATION TYPE I [JUVENILE TYPE] UNCONTROLLED
252.00 HYPERPARATHYROIDISM UNSPECIFIED
252.01 PRIMARY HYPERPARATHYROIDISM
252.02 SECONDARY HYPERPARATHYROIDISM NONRENAL
252.08 OTHER HYPERPARATHYROIDISM
263.1 MALNUTRITION OF MILD DEGREE
263.9 UNSPECIFIED PROTEIN-CALORIE MALNUTRITION
268.0 RICKETS ACTIVE
268.2 OSTEOMALACIA UNSPECIFIED
269.0 DEFICIENCY OF VITAMIN K
270.2 OTHER DISTURBANCES OF AROMATIC AMINO-ACID METABOLISM
270.9 UNSPECIFIED DISORDER OF AMINO-ACID METABOLISM
271.0 GLYCOGENOSIS
272.0 PURE HYPERCHOLESTEROLEMIA
272.1 PURE HYPERGLYCERIDEMIA
272.2 MIXED HYPERLIPIDEMIA
272.4 OTHER AND UNSPECIFIED HYPERLIPIDEMIA
272.7 LIPIDOSES
272.9 UNSPECIFIED DISORDER OF LIPOID METABOLISM
273.4 ALPHA-1-ANTITRYPSIN DEFICIENCY
275.0 DISORDERS OF IRON METABOLISM
275.1 DISORDERS OF COPPER METABOLISM
275.2 DISORDERS OF MAGNESIUM METABOLISM
275.3 DISORDERS OF PHOSPHORUS METABOLISM
275.40 UNSPECIFIED DISORDER OF CALCIUM METABOLISM
275.41 HYPOCALCEMIA
275.42 HYPERCALCEMIA
275.49 OTHER DISORDERS OF CALCIUM METABOLISM
275.5 HUNGRY BONE SYNDROME
277.1 DISORDERS OF PORPHYRIN METABOLISM
277.30 AMYLOIDOSIS UNSPECIFIED
277.31 FAMILIAL MEDITERRANEAN FEVER
277.39 OTHER AMYLOIDOSIS
277.4 DISORDERS OF BILIRUBIN EXCRETION
277.6 OTHER DEFICIENCIES OF CIRCULATING ENZYMES
282.60 SICKLE-CELL DISEASE UNSPECIFIED
282.61 HB-SS DISEASE WITHOUT CRISIS
282.62 HB-SS DISEASE WITH CRISIS
282.63 SICKLE-CELL/HB-C DISEASE WITHOUT CRISIS
282.64 SICKLE-CELL/HB C DISEASE WITH CRISIS
282.68 OTHER SICKLE-CELL DISEASE WITHOUT CRISIS
282.69 OTHER SICKLE-CELL DISEASE WITH CRISIS
286.6 DEFIBRINATION SYNDROME
286.7 ACQUIRED COAGULATION FACTOR DEFICIENCY
289.4 HYPERSPLENISM
289.52 SPLENIC SEQUESTRATION
291.0 ALCOHOL WITHDRAWAL DELIRIUM
291.1 ALCOHOL-INDUCED PERSISTING AMNESTIC DISORDER
291.2 ALCOHOL-INDUCED PERSISTING DEMENTIA
291.3 ALCOHOL-INDUCED PSYCHOTIC DISORDER WITH HALLUCINATIONS
291.4 IDIOSYNCRATIC ALCOHOL INTOXICATION
291.5 ALCOHOL-INDUCED PSYCHOTIC DISORDER WITH DELUSIONS
291.81 ALCOHOL WITHDRAWAL
291.82 ALCOHOL-INDUCED SLEEP DISORDERS
291.89 OTHER SPECIFIED ALCOHOL-INDUCED MENTAL DISORDERS
291.9 UNSPECIFIED ALCOHOL-INDUCED MENTAL DISORDERS
303.00 ACUTE ALCOHOLIC INTOXICATION IN ALCOHOLISM UNSPECIFIED DRINKING BEHAVIOR
303.01 ACUTE ALCOHOLIC INTOXICATION IN ALCOHOLISM CONTINUOUS DRINKING BEHAVIOR
303.02 ACUTE ALCOHOLIC INTOXICATION IN ALCOHOLISM EPISODIC DRINKING BEHAVIOR
303.03 ACUTE ALCOHOLIC INTOXICATION IN ALCOHOLISM IN REMISSION
303.90 OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE UNSPECIFIED DRINKING BEHAVIOR
303.91 OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE CONTINUOUS DRINKING BEHAVIOR
303.92 OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE EPISODIC DRINKING BEHAVIOR
303.93 OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE IN REMISSION
304.00 OPIOID TYPE DEPENDENCE UNSPECIFIED USE
304.01 OPIOID TYPE DEPENDENCE CONTINUOUS USE
304.02 OPIOID TYPE DEPENDENCE EPISODIC USE
304.03 OPIOID TYPE DEPENDENCE IN REMISSION
304.10 "SEDATIVE, HYPNOTIC OR ANXIOLYTIC DEPENDENCE UNSPECIFIED USE"
304.11 "SEDATIVE, HYPNOTIC OR ANXIOLYTIC DEPENDENCE CONTINUOUS USE"
304.12 "SEDATIVE, HYPNOTIC OR ANXIOLYTIC DEPENDENCE EPISODIC USE"
304.13 "SEDATIVE, HYPNOTIC OR ANXIOLYTIC DEPENDENCE IN REMISSION"
304.20 COCAINE DEPENDENCE UNSPECIFIED USE
304.21 COCAINE DEPENDENCE CONTINUOUS USE
304.22 COCAINE DEPENDENCE EPISODIC USE
304.23 COCAINE DEPENDENCE IN REMISSION
304.30 CANNABIS DEPENDENCE UNSPECIFIED USE
304.31 CANNABIS DEPENDENCE CONTINUOUS USE
304.32 CANNABIS DEPENDENCE EPISODIC USE
304.33 CANNABIS DEPENDENCE IN REMISSION
304.40 AMPHETAMINE AND OTHER PSYCHOSTIMULANT DEPENDENCE UNSPECIFIED USE
304.41 AMPHETAMINE AND OTHER PSYCHOSTIMULANT DEPENDENCE CONTINUOUS USE
304.42 AMPHETAMINE AND OTHER PSYCHOSTIMULANT DEPENDENCE EPISODIC USE
304.43 AMPHETAMINE AND OTHER PSYCHOSTIMULANT DEPENDENCE IN REMISSION
304.50 HALLUCINOGEN DEPENDENCE UNSPECIFIED USE
304.51 HALLUCINOGEN DEPENDENCE CONTINUOUS USE
304.52 HALLUCINOGEN DEPENDENCE EPISODIC USE
304.53 HALLUCINOGEN DEPENDENCE IN REMISSION
304.60 OTHER SPECIFIED DRUG DEPENDENCE UNSPECIFIED USE
304.61 OTHER SPECIFIED DRUG DEPENDENCE CONTINUOUS USE
304.62 OTHER SPECIFIED DRUG DEPENDENCE EPISODIC USE
304.63 OTHER SPECIFIED DRUG DEPENDENCE IN REMISSION
304.70 COMBINATIONS OF OPIOID TYPE DRUG WITH ANY OTHER DRUG DEPENDENCE UNSPECIFIED USE
304.71 COMBINATIONS OF OPIOID TYPE DRUG WITH ANY OTHER DRUG DEPENDENCE CONTINUOUS USE
304.72 COMBINATIONS OF OPIOID TYPE DRUG WITH ANY OTHER DRUG DEPENDENCE EPISODIC USE
304.73 COMBINATIONS OF OPIOID TYPE DRUG WITH ANY OTHER DRUG DEPENDENCE IN REMISSION
304.80 COMBINATIONS OF DRUG DEPENDENCE EXCLUDING OPIOID TYPE DRUG UNSPECIFIED USE
304.81 COMBINATIONS OF DRUG DEPENDENCE EXCLUDING OPIOID TYPE DRUG CONTINUOUS USE
304.82 COMBINATIONS OF DRUG DEPENDENCE EXCLUDING OPIOID TYPE DRUG EPISODIC USE
304.83 COMBINATIONS OF DRUG DEPENDENCE EXCLUDING OPIOID TYPE DRUG IN REMISSION
304.90 UNSPECIFIED DRUG DEPENDENCE UNSPECIFIED USE
304.91 UNSPECIFIED DRUG DEPENDENCE CONTINUOUS USE
304.92 UNSPECIFIED DRUG DEPENDENCE EPISODIC USE
304.93 UNSPECIFIED DRUG DEPENDENCE IN REMISSION
305.00 NONDEPENDENT ALCOHOL ABUSE UNSPECIFIED DRINKING BEHAVIOR
305.01 NONDEPENDENT ALCOHOL ABUSE CONTINUOUS DRINKING BEHAVIOR
305.02 NONDEPENDENT ALCOHOL ABUSE EPISODIC DRINKING BEHAVIOR
305.03 NONDEPENDENT ALCOHOL ABUSE IN REMISSION
305.1 NONDEPENDENT TOBACCO USE DISORDER
305.20 NONDEPENDENT CANNABIS ABUSE UNSPECIFIED USE
305.21 NONDEPENDENT CANNABIS ABUSE CONTINUOUS USE
305.22 NONDEPENDENT CANNABIS ABUSE EPISODIC USE
305.23 NONDEPENDENT CANNABIS ABUSE IN REMISSION
305.30 NONDEPENDENT HALLUCINOGEN ABUSE UNSPECIFIED USE
305.31 NONDEPENDENT HALLUCINOGEN ABUSE CONTINUOUS USE
305.32 NONDEPENDENT HALLUCINOGEN ABUSE EPISODIC USE
305.33 NONDEPENDENT HALLUCINOGEN ABUSE IN REMISSION
305.40 "NONDEPENDENT SEDATIVE, HYPNOTIC OR ANXIOLYTIC ABUSE UNSPECIFIED USE"
305.41 "NONDEPENDENT SEDATIVE, HYPNOTIC OR ANXIOLYTIC ABUSE CONTINUOUS USE"
305.42 "NONDEPENDENT SEDATIVE, HYPNOTIC OR ANXIOLYTIC ABUSE EPISODIC USE"
305.43 "NONDEPENDENT SEDATIVE, HYPNOTIC OR ANXIOLYTIC ABUSE IN REMISSION"
305.50 NONDEPENDENT OPIOID ABUSE UNSPECIFIED USE
305.51 NONDEPENDENT OPIOID ABUSE CONTINUOUS USE
305.52 NONDEPENDENT OPIOID ABUSE EPISODIC USE
305.53 NONDEPENDENT OPIOID ABUSE IN REMISSION
305.60 NONDEPENDENT COCAINE ABUSE UNSPECIFIED USE
305.61 NONDEPENDENT COCAINE ABUSE CONTINUOUS USE
305.62 NONDEPENDENT COCAINE ABUSE EPISODIC USE
305.63 NONDEPENDENT COCAINE ABUSE IN REMISSION
305.70 NONDEPENDENT AMPHETAMINE OR RELATED ACTING SYMPATHOMIMETIC ABUSE UNSPECIFIED USE
305.71 NONDEPENDENT AMPHETAMINE OR RELATED ACTING SYMPATHOMIMETIC ABUSE CONTINUOUS USE
305.72 NONDEPENDENT AMPHETAMINE OR RELATED ACTING SYMPATHOMIMETIC ABUSE EPISODIC USE
305.73 NONDEPENDENT AMPHETAMINE OR RELATED ACTING SYMPATHOMIMETIC ABUSE IN REMISSION
305.80 NONDEPENDENT ANTIDEPRESSANT TYPE ABUSE UNSPECIFIED USE
305.81 NONDEPENDENT ANTIDEPRESSANT TYPE ABUSE CONTINUOUS USE
305.82 NONDEPENDENT ANTIDEPRESSANT TYPE ABUSE EPISODIC USE
305.83 NONDEPENDENT ANTIDEPRESSANT TYPE ABUSE IN REMISSION
305.90 OTHER MIXED OR UNSPECIFIED DRUG ABUSE UNSPECIFIED USE
305.91 NONDEPENDENT OTHER MIXED OR UNSPECIFIED DRUG ABUSE CONTINUOUS USE
305.92 NONDEPENDENT OTHER MIXED OR UNSPECIFIED DRUG ABUSE EPISODIC USE
305.93 NONDEPENDENT OTHER MIXED OR UNSPECIFIED DRUG ABUSE IN REMISSION
357.5 ALCOHOLIC POLYNEUROPATHY
359.21 MYOTONIC MUSCULAR DYSTROPHY
359.22 MYOTONIA CONGENITA
359.23 MYOTONIC CHONDRODYSTROPHY
359.24 DRUG-INDUCED MYOTONIA
359.29 OTHER SPECIFIED MYOTONIC DISORDER
452 PORTAL VEIN THROMBOSIS
453.0 BUDD-CHIARI SYNDROME
453.1 THROMBOPHLEBITIS MIGRANS
453.2 EMBOLISM AND THROMBOSIS OF VENA CAVA
453.3 EMBOLISM AND THROMBOSIS OF RENAL VEIN
453.40 VENOUS EMBOLISM AND THROMBOSIS OF UNSPECIFIED DEEP VESSELS OF LOWER EXTREMITY
453.41 VENOUS EMBOLISM AND THROMBOSIS OF DEEP VESSELS OF PROXIMAL LOWER EXTREMITY
453.42 VENOUS EMBOLISM AND THROMBOSIS OF DEEP VESSELS OF DISTAL LOWER EXTREMITY
453.8 EMBOLISM AND THROMBOSIS OF OTHER SPECIFIED VEINS
453.9 EMBOLISM AND THROMBOSIS OF UNSPECIFIED SITE
453.40 VENOUS EMBOLISM AND THROMBOSIS OF UNSPECIFIED DEEP VESSELS OF LOWER EXTREMITY
453.41 VENOUS EMBOLISM AND THROMBOSIS OF DEEP VESSELS OF PROXIMAL LOWER EXTREMITY
453.42 VENOUS EMBOLISM AND THROMBOSIS OF DEEP VESSELS OF DISTAL LOWER EXTREMITY
456.0 ESOPHAGEAL VARICES WITH BLEEDING
456.1 ESOPHAGEAL VARICES WITHOUT BLEEDING
456.20 ESOPHAGEAL VARICES IN DISEASES CLASSIFIED ELSEWHERE WITH BLEEDING
456.21 ESOPHAGEAL VARICES IN DISEASES CLASSIFIED ELSEWHERE WITHOUT BLEEDING
555.0 REGIONAL ENTERITIS OF SMALL INTESTINE
555.1 REGIONAL ENTERITIS OF LARGE INTESTINE
555.2 REGIONAL ENTERITIS OF SMALL INTESTINE WITH LARGE INTESTINE
555.9 REGIONAL ENTERITIS OF UNSPECIFIED SITE
556.0 ULCERATIVE (CHRONIC) ENTEROCOLITIS
556.1 ULCERATIVE (CHRONIC) ILEOCOLITIS
556.2 ULCERATIVE (CHRONIC) PROCTITIS
556.3 ULCERATIVE (CHRONIC) PROCTOSIGMOIDITIS
556.4 PSEUDOPOLYPOSIS OF COLON
556.5 LEFT-SIDED ULCERATIVE (CHRONIC) COLITIS
556.6 UNIVERSAL ULCERATIVE (CHRONIC) COLITIS
556.8 OTHER ULCERATIVE COLITIS
556.9 ULCERATIVE COLITIS UNSPECIFIED
557.0 ACUTE VASCULAR INSUFFICIENCY OF INTESTINE
558.1 GASTROENTERITIS AND COLITIS DUE TO RADIATION
558.2 TOXIC GASTROENTERITIS AND COLITIS
558.3 ALLERGIC GASTROENTERITIS AND COLITIS
558.41 EOSINOPHILIC GASTROENTERITIS
558.42 EOSINOPHILIC COLITIS
558.9 OTHER AND UNSPECIFIED NONINFECTIOUS GASTROENTERITIS AND COLITIS
558.41 EOSINOPHILIC GASTROENTERITIS
558.42 EOSINOPHILIC COLITIS
560.0 INTUSSUSCEPTION
560.1 PARALYTIC ILEUS
560.2 VOLVULUS OF INTESTINE
560.30 IMPACTION OF INTESTINE UNSPECIFIED
560.31 GALLSTONE ILEUS
560.39 OTHER IMPACTION OF INTESTINE
560.81 INTESTINAL OR PERITONEAL ADHESIONS WITH OBSTRUCTION (POSTOPERATIVE) (POSTINFECTION)
560.89 OTHER SPECIFIED INTESTINAL OBSTRUCTION
560.9 UNSPECIFIED INTESTINAL OBSTRUCTION
562.01 DIVERTICULITIS OF SMALL INTESTINE (WITHOUT HEMORRHAGE)
562.03 DIVERTICULITIS OF SMALL INTESTINE WITH HEMORRHAGE
562.11 DIVERTICULITIS OF COLON (WITHOUT HEMORRHAGE)
562.13 DIVERTICULITIS OF COLON WITH HEMORRHAGE
567.0 PERITONITIS IN INFECTIOUS DISEASES CLASSIFIED ELSEWHERE
567.1 PNEUMOCOCCAL PERITONITIS
567.21 PERITONITIS (ACUTE) GENERALIZED
567.22 PERITONEAL ABSCESS
567.23 SPONTANEOUS BACTERIAL PERITONITIS
567.29 OTHER SUPPURATIVE PERITONITIS
567.38 OTHER RETROPERITONEAL ABSCESS
567.39 OTHER RETROPERITONEAL INFECTIONS
567.81 CHOLEPERITONITIS
567.82 SCLEROSING MESENTERITIS
567.89 OTHER SPECIFIED PERITONITIS
567.9 UNSPECIFIED PERITONITIS
569.83 PERFORATION OF INTESTINE
570 ACUTE AND SUBACUTE NECROSIS OF LIVER
571.0 ALCOHOLIC FATTY LIVER
571.1 ACUTE ALCOHOLIC HEPATITIS
571.2 ALCOHOLIC CIRRHOSIS OF LIVER
571.3 ALCOHOLIC LIVER DAMAGE UNSPECIFIED
571.40 CHRONIC HEPATITIS UNSPECIFIED
571.41 CHRONIC PERSISTENT HEPATITIS
571.42 AUTOIMMUNE HEPATITIS
571.49 OTHER CHRONIC HEPATITIS
571.5 CIRRHOSIS OF LIVER WITHOUT ALCOHOL
571.6 BILIARY CIRRHOSIS
571.8 OTHER CHRONIC NONALCOHOLIC LIVER DISEASE
571.9 UNSPECIFIED CHRONIC LIVER DISEASE WITHOUT ALCOHOL
571.42 AUTOIMMUNE HEPATITIS
572.0 ABSCESS OF LIVER
572.1 PORTAL PYEMIA
572.2 HEPATIC COMA
572.3 PORTAL HYPERTENSION
572.4 HEPATORENAL SYNDROME
572.8 OTHER SEQUELAE OF CHRONIC LIVER DISEASE
573.0 CHRONIC PASSIVE CONGESTION OF LIVER
573.1 HEPATITIS IN VIRAL DISEASES CLASSIFIED ELSEWHERE
573.2 HEPATITIS IN OTHER INFECTIOUS DISEASES CLASSIFIED ELSEWHERE
573.3 HEPATITIS UNSPECIFIED
573.4 HEPATIC INFARCTION
573.8 OTHER SPECIFIED DISORDERS OF LIVER
573.9 UNSPECIFIED DISORDER OF LIVER
574.00 CALCULUS OF GALLBLADDER WITH ACUTE CHOLECYSTITIS WITHOUT OBSTRUCTION
574.01 CALCULUS OF GALLBLADDER WITH ACUTE CHOLECYSTITIS WITH OBSTRUCTION
574.10 CALCULUS OF GALLBLADDER WITH OTHER CHOLECYSTITIS WITHOUT OBSTRUCTION
574.11 CALCULUS OF GALLBLADDER WITH OTHER CHOLECYSTITIS WITH OBSTRUCTION
574.20 CALCULUS OF GALLBLADDER WITHOUT CHOLECYSTITIS WITHOUT OBSTRUCTION
574.21 CALCULUS OF GALLBLADDER WITHOUT CHOLECYSTITIS WITH OBSTRUCTION
574.30 CALCULUS OF BILE DUCT WITH ACUTE CHOLECYSTITIS WITHOUT OBSTRUCTION
574.31 CALCULUS OF BILE DUCT WITH ACUTE CHOLECYSTITIS WITH OBSTRUCTION
574.40 CALCULUS OF BILE DUCT WITH OTHER CHOLECYSTITIS WITHOUT OBSTRUCTION
574.41 CALCULUS OF BILE DUCT WITH OTHER CHOLECYSTITIS WITH OBSTRUCTION
574.50 CALCULUS OF BILE DUCT WITHOUT CHOLECYSTITIS WITHOUT OBSTRUCTION
574.51 CALCULUS OF BILE DUCT WITHOUT CHOLECYSTITIS WITH OBSTRUCTION
574.60 CALCULUS OF GALLBLADDER AND BILE DUCT WITH ACUTE CHOLECYSTITIS WITHOUT OBSTRUCTION
574.61 CALCULUS OF GALLBLADDER AND BILE DUCT WITH ACUTE CHOLECYSTITIS WITH OBSTRUCTION
574.70 CALCULUS OF GALLBLADDER AND BILE DUCT WITH OTHER CHOLECYSTITIS WITHOUT OBSTRUCTION
574.71 CALCULUS OF GALLBLADDER AND BILE DUCT WITH OTHER CHOLECYSTITIS WITH OBSTRUCTION
574.80 CALCULUS OF GALLBLADDER AND BILE DUCT WITH ACUTE AND CHRONIC CHOLECYSTITIS WITHOUT OBSTRUCTION
574.81 CALCULUS OF GALLBLADDER AND BILE DUCT WITH ACUTE AND CHRONIC CHOLECYSTITIS WITH OBSTRUCTION
574.90 CALCULUS OF GALLBLADDER AND BILE DUCT WITHOUT CHOLECYSTITIS WITHOUT OBSTRUCTION
574.91 CALCULUS OF GALLBLADDER AND BILE DUCT WITHOUT CHOLECYSTITIS WITH OBSTRUCTION
575.0 ACUTE CHOLECYSTITIS
575.10 CHOLECYSTITIS UNSPECIFIED
575.11 CHRONIC CHOLECYSTITIS
575.12 ACUTE AND CHRONIC CHOLECYSTITIS
575.2 OBSTRUCTION OF GALLBLADDER
575.3 HYDROPS OF GALLBLADDER
575.4 PERFORATION OF GALLBLADDER
575.5 FISTULA OF GALLBLADDER
575.6 CHOLESTEROLOSIS OF GALLBLADDER
575.8 OTHER SPECIFIED DISORDERS OF GALLBLADDER
575.9 UNSPECIFIED DISORDER OF GALLBLADDER
576.0 POSTCHOLECYSTECTOMY SYNDROME
576.1 CHOLANGITIS
576.2 OBSTRUCTION OF BILE DUCT
576.3 PERFORATION OF BILE DUCT
576.4 FISTULA OF BILE DUCT
576.5 SPASM OF SPHINCTER OF ODDI
576.8 OTHER SPECIFIED DISORDERS OF BILIARY TRACT
576.9 UNSPECIFIED DISORDER OF BILIARY TRACT
581.0 NEPHROTIC SYNDROME WITH LESION OF PROLIFERATIVE GLOMERULONEPHRITIS
581.1 NEPHROTIC SYNDROME WITH LESION OF MEMBRANOUS GLOMERULONEPHRITIS
581.2 NEPHROTIC SYNDROME WITH LESION OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
581.3 NEPHROTIC SYNDROME WITH LESION OF MINIMAL CHANGE GLOMERULONEPHRITIS
581.81 NEPHROTIC SYNDROME IN DISEASES CLASSIFIED ELSEWHERE
581.89 OTHER NEPHROTIC SYNDROME WITH SPECIFIED PATHOLOGICAL LESION IN KIDNEY
581.9 NEPHROTIC SYNDROME WITH UNSPECIFIED PATHOLOGICAL LESION IN KIDNEY
582.0 CHRONIC GLOMERULONEPHRITIS WITH LESION OF PROLIFERATIVE GLOMERULONEPHRITIS
582.1 CHRONIC GLOMERULONEPHRITIS WITH LESION OF MEMBRANOUS GLOMERULONEPHRITIS
582.2 CHRONIC GLOMERULONEPHRITIS WITH LESION OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
582.4 CHRONIC GLOMERULONEPHRITIS WITH LESION OF RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS
582.81 CHRONIC GLOMERULONEPHRITIS IN DISEASES CLASSIFIED ELSEWHERE
582.89 OTHER CHRONIC GLOMERULONEPHRITIS WITH SPECIFIED PATHOLOGICAL LESION IN KIDNEY
582.9 CHRONIC GLOMERULONEPHRITIS WITH UNSPECIFIED PATHOLOGICAL LESION IN KIDNEY
583.0 NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC WITH LESION OF PROLIFERATIVE GLOMERULONEPHRITIS
583.1 NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC WITH LESION OF MEMBRANOUS GLOMERULONEPHRITIS
583.2 NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC WITH LESION OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
583.4 NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC WITH LESION OF RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS
583.6 NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC WITH LESION OF RENAL CORTICAL NECROSIS
583.7 NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC WITH LESION OF RENAL MEDULLARY NECROSIS
583.81 NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC IN DISEASES CLASSIFIED ELSEWHERE
583.89 OTHER NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC WITH SPECIFIED PATHOLOGICAL LESION IN KIDNEY
583.9 NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC WITH UNSPECIFIED PATHOLOGICAL LESION IN KIDNEY
584.5 ACUTE RENAL FAILURE WITH LESION OF TUBULAR NECROSIS
584.6 ACUTE RENAL FAILURE WITH LESION OF RENAL CORTICAL NECROSIS
584.7 ACUTE RENAL FAILURE WITH LESION OF RENAL MEDULLARY (PAPILLARY) NECROSIS
584.8 ACUTE RENAL FAILURE WITH OTHER SPECIFIED PATHOLOGICAL LESION IN KIDNEY
584.9 ACUTE RENAL FAILURE UNSPECIFIED
585.6 END STAGE RENAL DISEASE
586 RENAL FAILURE UNSPECIFIED
587 RENAL SCLEROSIS UNSPECIFIED
588.0 RENAL OSTEODYSTROPHY
588.1 NEPHROGENIC DIABETES INSIPIDUS
588.81 SECONDARY HYPERPARATHYROIDISM (OF RENAL ORIGIN)
588.89 OTHER SPECIFIED DISORDERS RESULTING FROM IMPAIRED RENAL FUNCTION
588.9 UNSPECIFIED DISORDER RESULTING FROM IMPAIRED RENAL FUNCTION
590.00 CHRONIC PYELONEPHRITIS WITHOUT LESION OF RENAL MEDULLARY NECROSIS
590.01 CHRONIC PYELONEPHRITIS WITH LESION OF RENAL MEDULLARY NECROSIS
590.10 ACUTE PYELONEPHRITIS WITHOUT LESION OF RENAL MEDULLARY NECROSIS
590.11 ACUTE PYELONEPHRITIS WITH LESION OF RENAL MEDULLARY NECROSIS
590.2 RENAL AND PERINEPHRIC ABSCESS
590.3 PYELOURETERITIS CYSTICA
590.80 PYELONEPHRITIS UNSPECIFIED
590.81 PYELITIS OR PYELONEPHRITIS IN DISEASES CLASSIFIED ELSEWHERE
590.9 INFECTION OF KIDNEY UNSPECIFIED
642.50 SEVERE PRE-ECLAMPSIA UNSPECIFIED AS TO EPISODE OF CARE
642.51 SEVERE PRE-ECLAMPSIA WITH DELIVERY
642.52 SEVERE PRE-ECLAMPSIA WITH DELIVERY WITH POSTPARTUM COMPLICATION
642.53 SEVERE PRE-ECLAMPSIA ANTEPARTUM
642.54 SEVERE PRE-ECLAMPSIA POSTPARTUM
646.70 LIVER DISORDERS IN PREGNANCY UNSPECIFIED AS TO EPISODE OF CARE
646.71 LIVER DISORDERS IN PREGNANCY WITH DELIVERY
646.73 ANTEPARTUM LIVER DISORDERS
782.4 JAUNDICE UNSPECIFIED NOT OF NEWBORN
789.1 HEPATOMEGALY
790.4 NONSPECIFIC ELEVATION OF LEVELS OF TRANSAMINASE OR LACTIC ACID DEHYDROGENASE (LDH)
790.5 OTHER NONSPECIFIC ABNORMAL SERUM ENZYME LEVELS
960.0 POISONING BY PENICILLINS
960.1 POISONING BY ANTIFUNGAL ANTIBIOTICS
960.2 POISONING BY CHLORAMPHENICOL GROUP
960.3 POISONING BY ERYTHROMYCIN AND OTHER MACROLIDES
960.4 POISONING BY TETRACYCLINE GROUP
960.5 POISONING OF CEPHALOSPORIN GROUP
960.6 POISONING OF ANTIMYCOBACTERIAL ANTIBIOTICS
960.7 POISONING BY ANTINEOPLASTIC ANTIBIOTICS
960.8 POISONING BY OTHER SPECIFIED ANTIBIOTICS
960.9 POISONING BY UNSPECIFIED ANTIBIOTIC
961.0 POISONING BY SULFONAMIDES
961.1 POISONING BY ARSENICAL ANTI-INFECTIVES
961.2 POISONING BY HEAVY METAL ANTI-INFECTIVES
961.3 POISONING BY QUINOLINE AND HYDROXYQUINOLINE DERIVATIVES
961.4 POISONING BY ANTIMALARIALS AND DRUGS ACTING ON OTHER BLOOD PROTOZOA
961.5 POISONING BY OTHER ANTIPROTOZOAL DRUGS
961.6 POISONING BY ANTHELMINTICS
961.7 POISONING BY ANTIVIRAL DRUGS
961.8 POISONING BY OTHER ANTIMYCOBACTERIAL DRUGS
961.9 POISONING BY OTHER AND UNSPECIFIED ANTI-INFECTIVES
962.0 POISONING BY ADRENAL CORTICAL STEROIDS
962.1 POISONING BY ANDROGENS AND ANABOLIC CONGENERS
962.2 POISONING BY OVARIAN HORMONES AND SYNTHETIC SUBSTITUTES
962.3 POISONING BY INSULINS AND ANTIDIABETIC AGENTS
962.4 POISONING BY ANTERIOR PITUITARY HORMONES
962.5 POISONING BY POSTERIOR PITUITARY HORMONES
962.6 POISONING BY PARATHYROID AND PARATHYROID DERIVATIVES
962.7 POISONING BY THYROID AND THYROID DERIVATIVES
962.8 POISONING BY ANTITHYROID AGENTS
962.9 POISONING BY OTHER AND UNSPECIFIED HORMONES AND SYNTHETIC SUBSTITUTES
963.0 POISONING BY ANTIALLERGIC AND ANTIEMETIC DRUGS
963.1 POISONING BY ANTINEOPLASTIC AND IMMUNOSUPPRESSIVE DRUGS
963.2 POISONING BY ACIDIFYING AGENTS
963.3 POISONING BY ALKALIZING AGENTS
963.4 POISONING BY ENZYMES NOT ELSEWHERE CLASSIFIED
963.5 POISONING BY VITAMINS NOT ELSEWHERE CLASSIFIED
963.8 POISONING BY OTHER SPECIFIED SYSTEMIC AGENTS
963.9 POISONING BY UNSPECIFIED SYSTEMIC AGENT
964.0 POISONING BY IRON AND ITS COMPOUNDS
964.1 POISONING BY LIVER PREPARATIONS AND OTHER ANTIANEMIC AGENTS
964.2 POISONING BY ANTICOAGULANTS
964.3 POISONING BY VITAMIN K (PHYTONADIONE)
964.4 POISONING BY FIBRINOLYSIS-AFFECTING DRUGS
964.5 POISONING BY ANTICOAGULANT ANTAGONISTS AND OTHER COAGULANTS
964.6 POISONING BY GAMMA GLOBULIN
964.7 POISONING BY NATURAL BLOOD AND BLOOD PRODUCTS
964.8 POISONING BY OTHER SPECIFIED AGENTS AFFECTING BLOOD CONSTITUENTS
964.9 POISONING BY UNSPECIFIED AGENT AFFECTING BLOOD CONSTITUENTS
965.00 POISONING BY OPIUM (ALKALOIDS) UNSPECIFIED
965.01 POISONING BY HEROIN
965.02 POISONING BY METHADONE
965.09 POISONING BY OTHER OPIATES AND RELATED NARCOTICS
965.1 POISONING BY SALICYLATES
965.4 POISONING BY AROMATIC ANALGESICS NOT ELSEWHERE CLASSIFIED
965.5 POISONING BY PYRAZOLE DERIVATIVES
965.61 POISONING BY PROPIONIC ACID DERIVATIVES
965.69 POISONING BY OTHER ANTIRHEUMATICS
965.7 POISONING BY OTHER NON-NARCOTIC ANALGESICS
965.8 POISONING BY OTHER SPECIFIED ANALGESICS AND ANTIPYRETICS
965.9 POISONING BY UNSPECIFIED ANALGESIC AND ANTIPYRETIC
966.0 POISONING BY OXAZOLIDINE DERIVATIVES
966.1 POISONING BY HYDANTOIN DERIVATIVES
966.2 POISONING BY SUCCINIMIDES
966.3 POISONING BY OTHER AND UNSPECIFIED ANTICONVULSANTS
966.4 POISONING BY ANTI-PARKINSONISM DRUGS
967.0 POISONING BY BARBITURATES
967.1 POISONING BY CHLORAL HYDRATE GROUP
967.2 POISONING BY PARALDEHYDE
967.3 POISONING BY BROMINE COMPOUNDS
967.4 POISONING BY METHAQUALONE COMPOUNDS
967.5 POISONING BY GLUTETHIMIDE GROUP
967.6 POISONING BY MIXED SEDATIVES NOT ELSEWHERE CLASSIFIED
967.8 POISONING BY OTHER SEDATIVES AND HYPNOTICS
967.9 POISONING BY UNSPECIFIED SEDATIVE OR HYPNOTIC
968.0 POISONING BY CENTRAL NERVOUS SYSTEM MUSCLE-TONE DEPRESSANTS
968.1 POISONING BY HALOTHANE
968.2 POISONING BY OTHER GASEOUS ANESTHETICS
968.3 POISONING BY INTRAVENOUS ANESTHETICS
968.4 POISONING BY OTHER AND UNSPECIFIED GENERAL ANESTHETICS
968.5 POISONING BY SURFACE (TOPICAL) AND INFILTRATION ANESTHETICS
968.6 POISONING BY PERIPHERAL NERVE- AND PLEXUS-BLOCKING ANESTHETICS
968.7 POISONING BY SPINAL ANESTHETICS
968.9 POISONING BY OTHER AND UNSPECIFIED LOCAL ANESTHETICS
969.0 POISONING BY ANTIDEPRESSANTS
969.1 POISONING BY PHENOTHIAZINE-BASED TRANQUILIZERS
969.2 POISONING BY BUTYROPHENONE-BASED TRANQUILIZERS
969.3 POISONING BY OTHER ANTIPSYCHOTICS NEUROLEPTICS AND MAJOR TRANQUILIZERS
969.4 POISONING BY BENZODIAZEPINE-BASED TRANQUILIZERS
969.5 POISONING BY OTHER TRANQUILIZERS
969.6 POISONING BY PSYCHODYSLEPTICS (HALLUCINOGENS)
969.7 POISONING BY PSYCHOSTIMULANTS
969.8 POISONING BY OTHER SPECIFIED PSYCHOTROPIC AGENTS
969.9 POISONING BY UNSPECIFIED PSYCHOTROPIC AGENT
970.0 POISONING BY ANALEPTICS
970.1 POISONING BY OPIATE ANTAGONISTS
970.8 POISONING BY OTHER SPECIFIED CENTRAL NERVOUS SYSTEM STIMULANTS
970.9 POISONING BY UNSPECIFIED CENTRAL NERVOUS SYSTEM STIMULANT
971.0 POISONING BY PARASYMPATHOMIMETICS (CHOLINERGICS)
971.1 POISONING BY PARASYMPATHOLYTICS (ANTICHOLINERGICS AND ANTIMUSCARINICS) AND SPASMOLYTICS
971.2 POISONING BY SYMPATHOMIMETICS (ADRENERGICS)
971.3 POISONING BY SYMPATHOLYTICS (ANTIADRENERGICS)
971.9 POISONING BY UNSPECIFIED DRUG PRIMARILY AFFECTING AUTONOMIC NERVOUS SYSTEM
972.0 POISONING BY CARDIAC RHYTHM REGULATORS
972.1 POISONING BY CARDIOTONIC GLYCOSIDES AND DRUGS OF SIMILAR ACTION
972.2 POISONING BY ANTILIPEMIC AND ANTIARTERIOSCLEROTIC DRUGS
972.3 POISONING BY GANGLION-BLOCKING AGENTS
972.4 POISONING BY CORONARY VASODILATORS
972.5 POISONING BY OTHER VASODILATORS
972.6 POISONING BY OTHER ANTIHYPERTENSIVE AGENTS
972.7 POISONING BY ANTIVARICOSE DRUGS INCLUDING SCLEROSING AGENTS
972.8 POISONING BY CAPILLARY-ACTIVE DRUGS
972.9 POISONING BY OTHER AND UNSPECIFIED AGENTS PRIMARILY AFFECTING THE CARDIOVASCULAR SYSTEM
973.0 POISONING BY ANTACIDS AND ANTIGASTRIC SECRETION DRUGS
973.1 POISONING BY IRRITANT CATHARTICS
973.2 POISONING BY EMOLLIENT CATHARTICS
973.3 POISONING BY OTHER CATHARTICS INCLUDING INTESTINAL ATONIA
973.4 POISONING BY DIGESTANTS
973.5 POISONING BY ANTIDIARRHEAL DRUGS
973.6 POISONING BY EMETICS
973.8 POISONING BY OTHER SPECIFIED AGENTS PRIMARILY AFFECTING THE GASTROINTESTINAL SYSTEM
973.9 POISONING BY UNSPECIFIED AGENT PRIMARILY AFFECTING THE GASTROINTESTINAL SYSTEM
974.0 POISONING BY MERCURIAL DIURETICS
974.1 POISONING BY PURINE DERIVATIVE DIURETICS
974.2 POISONING BY CARBONIC ACID ANHYDRASE INHIBITORS
974.3 POISONING BY SALURETICS
974.4 POISONING BY OTHER DIURETICS
974.5 POISONING BY ELECTROLYTIC CALORIC AND WATER-BALANCE AGENTS
974.6 POISONING BY OTHER MINERAL SALTS NOT ELSEWHERE CLASSIFIED
974.7 POISONING BY URIC ACID METABOLISM DRUGS
975.0 POISONING BY OXYTOCIC AGENTS
975.1 POISONING BY SMOOTH MUSCLE RELAXANTS
975.2 POISONING BY SKELETAL MUSCLE RELAXANTS
975.3 POISONING BY OTHER AND UNSPECIFIED DRUGS ACTING ON MUSCLES
975.4 POISONING BY ANTITUSSIVES
975.5 POISONING BY EXPECTORANTS
975.6 POISONING BY ANTI-COMMON COLD DRUGS
975.7 POISONING BY ANTIASTHMATICS
975.8 POISONING BY OTHER AND UNSPECIFIED RESPIRATORY DRUGS
976.0 POISONING BY LOCAL ANTI-INFECTIVES AND ANTI-INFLAMMATORY DRUGS
976.1 POISONING BY ANTIPRURITICS
976.2 POISONING BY LOCAL ASTRINGENTS AND LOCAL DETERGENTS
976.3 POISONING BY EMOLLIENTS DEMULCENTS AND PROTECTANTS
976.4 POISONING BY KERATOLYTICS KERATOPLASTICS OTHER HAIR TREATMENT DRUGS AND PREPARATIONS
976.5 POISONING BY EYE ANTI-INFECTIVES AND OTHER EYE DRUGS
976.6 POISONING BY ANTI-INFECTIVES AND OTHER DRUGS AND PREPARATIONS FOR EAR NOSE AND THROAT
976.7 POISONING BY DENTAL DRUGS TOPICALLY APPLIED
976.8 POISONING BY OTHER AGENTS PRIMARILY AFFECTING SKIN AND MUCOUS MEMBRANE
976.9 POISONING BY UNSPECIFIED AGENT PRIMARILY AFFECTING SKIN AND MUCOUS MEMBRANE
977.0 POISONING BY DIETETICS
977.1 POISONING BY LIPOTROPIC DRUGS
977.2 POISONING BY ANTIDOTES AND CHELATING AGENTS NOT ELSEWHERE CLASSIFIED
977.3 POISONING BY ALCOHOL DETERRENTS
977.4 POISONING BY PHARMACEUTICAL EXCIPIENTS
977.8 POISONING BY OTHER SPECIFIED DRUGS AND MEDICINAL SUBSTANCES
977.9 POISONING BY UNSPECIFIED DRUG OR MEDICINAL SUBSTANCE
978.0 POISONING BY BCG VACCINE
978.1 POISONING BY TYPHOID AND PARATYPHOID VACCINE
978.2 POISONING BY CHOLERA VACCINE
978.3 POISONING BY PLAGUE VACCINE
978.4 POISONING BY TETANUS VACCINE
978.5 POISONING BY DIPHTHERIA VACCINE
978.6 POISONING BY PERTUSSIS VACCINE INCLUDING COMBINATIONS WITH A PERTUSSIS COMPONENT
978.8 POISONING BY OTHER AND UNSPECIFIED BACTERIAL VACCINES
978.9 POISONING BY MIXED BACTERIAL VACCINES EXCEPT COMBINATIONS WITH A PERTUSSIS COMPONENT
979.0 POISONING BY SMALLPOX VACCINE
979.1 POISONING BY RABIES VACCINE
979.2 POISONING BY TYPHUS VACCINE
979.3 POISONING BY YELLOW FEVER VACCINE
979.4 POISONING BY MEASLES VACCINE
979.5 POISONING BY POLIOMYELITIS VACCINE
979.6 POISONING BY OTHER AND UNSPECIFIED VIRAL AND RICKETTSIAL VACCINES
979.7 POISONING BY MIXED VIRAL-RICKETTSIAL AND BACTERIAL VACCINES EXCEPT COMBINATIONS WITH A PERTUSSIS COMPONENT
979.9 POISONING BY OTHER AND UNSPECIFIED VACCINES AND BIOLOGICAL SUBSTANCES
980.0 TOXIC EFFECT OF ETHYL ALCOHOL
980.1 TOXIC EFFECT OF METHYL ALCOHOL
980.2 TOXIC EFFECT OF ISOPROPYL ALCOHOL
980.3 TOXIC EFFECT OF FUSEL OIL
980.8 TOXIC EFFECT OF OTHER SPECIFIED ALCOHOLS
980.9 TOXIC EFFECT OF UNSPECIFIED ALCOHOL
981 TOXIC EFFECT OF PETROLEUM PRODUCTS
982.0 TOXIC EFFECT OF BENZENE AND HOMOLOGUES
982.1 TOXIC EFFECT OF CARBON TETRACHLORIDE
982.2 TOXIC EFFECT OF CARBON DISULFIDE
982.3 TOXIC EFFECT OF OTHER CHLORINATED HYDROCARBON SOLVENTS
982.4 TOXIC EFFECT OF NITROGLYCOL
982.8 TOXIC EFFECT OF OTHER NONPETROLEUM-BASED SOLVENTS
983.0 TOXIC EFFECT OF CORROSIVE AROMATICS
983.1 TOXIC EFFECT OF ACIDS
983.2 TOXIC EFFECT OF CAUSTIC ALKALIS
983.9 TOXIC EFFECT OF CAUSTIC UNSPECIFIED
984.0 TOXIC EFFECT OF INORGANIC LEAD COMPOUNDS
984.1 TOXIC EFFECT OF ORGANIC LEAD COMPOUNDS
984.8 TOXIC EFFECT OF OTHER LEAD COMPOUNDS
984.9 TOXIC EFFECT OF UNSPECIFIED LEAD COMPOUND
985.0 TOXIC EFFECT OF MERCURY AND ITS COMPOUNDS
985.1 TOXIC EFFECT OF ARSENIC AND ITS COMPOUNDS
985.2 TOXIC EFFECT OF MANGANESE AND ITS COMPOUNDS
985.3 TOXIC EFFECT OF BERYLLIUM AND ITS COMPOUNDS
985.4 TOXIC EFFECT OF ANTIMONY AND ITS COMPOUNDS
985.5 TOXIC EFFECT OF CADMIUM AND ITS COMPOUNDS
985.6 TOXIC EFFECT OF CHROMIUM
985.8 TOXIC EFFECT OF OTHER SPECIFIED METALS
985.9 TOXIC EFFECT OF UNSPECIFIED METAL
986 TOXIC EFFECT OF CARBON MONOXIDE
987.0 TOXIC EFFECT OF LIQUEFIED PETROLEUM GASES
987.1 TOXIC EFFECT OF OTHER HYDROCARBON GAS
987.2 TOXIC EFFECT OF NITROGEN OXIDES
987.3 TOXIC EFFECT OF SULFUR DIOXIDE
987.4 TOXIC EFFECT OF FREON
987.5 TOXIC EFFECT OF LACRIMOGENIC GAS
987.6 TOXIC EFFECT OF CHLORINE GAS
987.7 TOXIC EFFECT OF HYDROCYANIC ACID GAS
987.8 TOXIC EFFECT OF OTHER SPECIFIED GASES FUMES OR VAPORS
987.9 TOXIC EFFECT OF UNSPECIFIED GAS FUME OR VAPOR
988.0 TOXIC EFFECT OF FISH AND SHELLFISH EATEN AS FOOD
988.1 TOXIC EFFECT OF MUSHROOMS EATEN AS FOOD
988.2 TOXIC EFFECT OF BERRIES AND OTHER PLANTS EATEN AS FOOD
988.8 TOXIC EFFECT OF OTHER SPECIFIED NOXIOUS SUBSTANCES EATEN AS FOOD
988.9 TOXIC EFFECT OF UNSPECIFIED NOXIOUS SUBSTANCE EATEN AS FOOD
989.0 TOXIC EFFECT OF HYDROCYANIC ACID AND CYANIDES
989.1 TOXIC EFFECT OF STRYCHNINE AND SALTS
989.2 TOXIC EFFECT OF CHLORINATED HYDROCARBONS
989.3 TOXIC EFFECT OF ORGANOPHOSPHATE AND CARBAMATE
989.4 TOXIC EFFECT OF OTHER PESTICIDES NOT ELSEWHERE CLASSIFIED
989.5 TOXIC EFFECT OF VENOM
989.6 TOXIC EFFECT OF SOAPS AND DETERGENTS
989.7 TOXIC EFFECT OF AFLATOXIN AND OTHER MYCOTOXIN (FOOD CONTAMINANTS)
989.81 TOXIC EFFECT OF ASBESTOS
989.82 TOXIC EFFECT OF LATEX
989.83 TOXIC EFFECT OF SILICONE
989.84 TOXIC EFFECT OF TOBACCO
989.89 TOXIC EFFECT OF OTHER SUBSTANCE CHIEFLY NONMEDICINAL AS TO SOURCE NOT ELSEWHERE CLASSIFIED
V42.7 LIVER REPLACED BY TRANSPLANT
V58.61 LONG-TERM (CURRENT) USE OF ANTICOAGULANTS
V58.62 LONG-TERM (CURRENT) USE OF ANTIBIOTICS
V58.63 LONG-TERM (CURRENT) USE OF ANTIPLATELETS/ANTITHROMBOTICS
V58.64 LONG-TERM (CURRENT) USE OF NONSTEROIDAL ANTI-INFLAMMATORIES
V58.69 LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS
V67.1 FOLLOW-UP EXAMINATION FOLLOWING RADIOTHERAPY
V67.2 FOLLOW-UP EXAMINATION FOLLOWING CHEMOTHERAPY
V67.51 FOLLOW-UP EXAMINATION FOLLOWING COMPLETED TREATMENT WITH HIGH-RISK MEDICATION NOT ELSEWHERE CLASSIFIED
UCSF home page UCSF home page About UCSF Search UCSF UCSF Medical Center